JP2001275691A - OPTICALLY ACTIVE beta-IMINO ALCOHOL AND beta-AMINO ALCOHOL, PRODUCTION INTERMEDIATE, AND METHOD FOR PRODUCING THEM - Google Patents
OPTICALLY ACTIVE beta-IMINO ALCOHOL AND beta-AMINO ALCOHOL, PRODUCTION INTERMEDIATE, AND METHOD FOR PRODUCING THEMInfo
- Publication number
- JP2001275691A JP2001275691A JP2000092551A JP2000092551A JP2001275691A JP 2001275691 A JP2001275691 A JP 2001275691A JP 2000092551 A JP2000092551 A JP 2000092551A JP 2000092551 A JP2000092551 A JP 2000092551A JP 2001275691 A JP2001275691 A JP 2001275691A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- reaction
- compound represented
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 57
- 239000004367 Lipase Substances 0.000 claims abstract description 19
- 102000004882 Lipase Human genes 0.000 claims abstract description 19
- 108090001060 Lipase Proteins 0.000 claims abstract description 19
- 235000019421 lipase Nutrition 0.000 claims abstract description 19
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 18
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 5
- 125000001188 haloalkyl group Chemical group 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 24
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 11
- 230000003301 hydrolyzing effect Effects 0.000 claims description 5
- 230000003287 optical effect Effects 0.000 abstract description 14
- 238000000034 method Methods 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 2
- 239000002243 precursor Substances 0.000 abstract description 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 90
- 238000006243 chemical reaction Methods 0.000 description 57
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 52
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 50
- 239000000203 mixture Substances 0.000 description 35
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- 238000005160 1H NMR spectroscopy Methods 0.000 description 27
- 239000000243 solution Substances 0.000 description 27
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 26
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 24
- -1 α-methylbenzyl Chemical group 0.000 description 23
- 239000000047 product Substances 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 238000010898 silica gel chromatography Methods 0.000 description 18
- 239000012043 crude product Substances 0.000 description 16
- 239000000706 filtrate Substances 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000012300 argon atmosphere Substances 0.000 description 12
- 239000012044 organic layer Substances 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 11
- 238000006460 hydrolysis reaction Methods 0.000 description 11
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 10
- WQADWIOXOXRPLN-UHFFFAOYSA-N 1,3-dithiane Chemical compound C1CSCSC1 WQADWIOXOXRPLN-UHFFFAOYSA-N 0.000 description 8
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 8
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 235000002597 Solanum melongena Nutrition 0.000 description 8
- 244000061458 Solanum melongena Species 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000004210 ether based solvent Substances 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 6
- 229910003002 lithium salt Inorganic materials 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 230000003197 catalytic effect Effects 0.000 description 5
- 239000012442 inert solvent Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 125000005262 alkoxyamine group Chemical group 0.000 description 4
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 4
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 229910052744 lithium Inorganic materials 0.000 description 4
- 159000000002 lithium salts Chemical class 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 3
- YGCZTXZTJXYWCO-UHFFFAOYSA-N 3-phenylpropanal Chemical compound O=CCCC1=CC=CC=C1 YGCZTXZTJXYWCO-UHFFFAOYSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 150000001733 carboxylic acid esters Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- 229940100892 mercury compound Drugs 0.000 description 3
- 150000002731 mercury compounds Chemical class 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 3
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 229930195734 saturated hydrocarbon Natural products 0.000 description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229940124321 AIDS medicine Drugs 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- GHDFLWGUFYIEBY-UHFFFAOYSA-M O.O.O.O.O.O.Cl(=O)(=O)(=O)[O-].[Hg+] Chemical compound O.O.O.O.O.O.Cl(=O)(=O)(=O)[O-].[Hg+] GHDFLWGUFYIEBY-UHFFFAOYSA-M 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- KDKYADYSIPSCCQ-UHFFFAOYSA-N but-1-yne Chemical compound CCC#C KDKYADYSIPSCCQ-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000005828 desilylation reaction Methods 0.000 description 2
- 239000012973 diazabicyclooctane Substances 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 2
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 2
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 2
- QVCUKHQDEZNNOC-UHFFFAOYSA-N 1,2-diazabicyclo[2.2.2]octane Chemical compound C1CC2CCN1NC2 QVCUKHQDEZNNOC-UHFFFAOYSA-N 0.000 description 1
- JLIDRDJNLAWIKT-UHFFFAOYSA-N 1,2-dimethyl-3h-benzo[e]indole Chemical compound C1=CC=CC2=C(C(=C(C)N3)C)C3=CC=C21 JLIDRDJNLAWIKT-UHFFFAOYSA-N 0.000 description 1
- CGHIBGNXEGJPQZ-UHFFFAOYSA-N 1-hexyne Chemical compound CCCCC#C CGHIBGNXEGJPQZ-UHFFFAOYSA-N 0.000 description 1
- IBXNCJKFFQIKKY-UHFFFAOYSA-N 1-pentyne Chemical compound CCCC#C IBXNCJKFFQIKKY-UHFFFAOYSA-N 0.000 description 1
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229940122440 HIV protease inhibitor Drugs 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- LDDQLRUQCUTJBB-UHFFFAOYSA-N ammonium fluoride Chemical class [NH4+].[F-] LDDQLRUQCUTJBB-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- DULCUDSUACXJJC-UHFFFAOYSA-N benzeneacetic acid ethyl ester Natural products CCOC(=O)CC1=CC=CC=C1 DULCUDSUACXJJC-UHFFFAOYSA-N 0.000 description 1
- 150000001576 beta-amino acids Chemical class 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- HFNMXYWDJQCFDD-UHFFFAOYSA-N ctk4h5792 Chemical compound [Li+].C1CS[CH-]SC1 HFNMXYWDJQCFDD-UHFFFAOYSA-N 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 239000004030 hiv protease inhibitor Substances 0.000 description 1
- XNXVOSBNFZWHBV-UHFFFAOYSA-N hydron;o-methylhydroxylamine;chloride Chemical compound Cl.CON XNXVOSBNFZWHBV-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- HYDZPXNVHXJHBG-UHFFFAOYSA-N o-benzylhydroxylamine;hydron;chloride Chemical compound Cl.NOCC1=CC=CC=C1 HYDZPXNVHXJHBG-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- HSAJRDKFYZAGLU-UHFFFAOYSA-M perchloryloxymercury Chemical compound [Hg+].[O-]Cl(=O)(=O)=O HSAJRDKFYZAGLU-UHFFFAOYSA-M 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- IWZKICVEHNUQTL-UHFFFAOYSA-M potassium hydrogen phthalate Chemical compound [K+].OC(=O)C1=CC=CC=C1C([O-])=O IWZKICVEHNUQTL-UHFFFAOYSA-M 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、医薬品製造中間体
等として有用な光学活性β−イミノアルコール類、β−
アミノアルコール類、これらの製造中間体およびそれら
の製造方法に関する。TECHNICAL FIELD The present invention relates to optically active β-imino alcohols and β-imino alcohols useful as intermediates for producing pharmaceuticals and the like
The present invention relates to amino alcohols, intermediates for producing them, and methods for producing them.
【0002】[0002]
【従来の技術】近年、式(15)で表されるα−ヒドロ
キシ−β−アミノ酸誘導体(BHP)が、式(16)で
表される抗エイズ薬(HIVプロテアーゼ阻害剤)のキ
ラルシントンとして注目され、このものの製造方法が種
々開発されている(下記式参照。)。2. Description of the Related Art In recent years, an α-hydroxy-β-amino acid derivative (BHP) represented by formula (15) has attracted attention as a chiral synthon of an anti-AIDS drug (HIV protease inhibitor) represented by formula (16). Various production methods have been developed (see the following formula).
【0003】[0003]
【化10】 Embedded image
【0004】従来、式(15)で表される化合物の製造
方法としては、次のものが知られている。 (1)EP.72939号公報に記載の方法Heretofore, the following method has been known as a method for producing the compound represented by the formula (15). (1) EP. No. 72939
【0005】[0005]
【化11】 Embedded image
【0006】(2)WO98/07687号公報に記載
の方法(2) The method described in WO98 / 07687
【0007】[0007]
【化12】 Embedded image
【0008】(3)WO98/11057号公報に記載
の方法(3) The method described in WO 98/11057
【0009】[0009]
【化13】 Embedded image
【0010】[0010]
【発明が解決しようとする課題】しかしながら上記した
方法は、比較的高価な貴金属触媒を用いるものであった
り、出発原料に天然物を用いるものであったり、得られ
るβ−アミノアルコ−ルの光学純度も必ずしも満足すべ
きものではなかったり等して、未だ確立された製造方法
であるとはいえないのが現状である。However, the above-mentioned method uses a relatively expensive noble metal catalyst, uses a natural product as a starting material, or obtains an optical system of β-amino alcohol obtained. At present, the purity is not always satisfactory and cannot be said to be an established production method.
【0011】そこで、本発明は、式(15)で表される
化合物に代表されるβ−アミノアルコール類及びその前
駆体であるβ−イミノアルコール類を高い光学純度で簡
便に製造することができる方法、並びにこれらの新規な
製造中間体を提供することを目的とする。Therefore, the present invention can easily produce β-amino alcohols represented by the compound represented by the formula (15) and β-imino alcohols which are precursors thereof with high optical purity. It is an object to provide a process, as well as these novel production intermediates.
【0012】[0012]
【課題を解決するための手段】本発明者らは上記課題を
解決すべく、加水分解酵素であるリパーゼを用いた式
(1)で表されるβ−イミノアルコール類の速度論的光
学分割の検討を行い、式(2)で表される化合物をリ
パーゼを用いて加水分解を行うことにより、式(1)で
表されるβ−イミノアルコール類を高い光学純度で簡便
に得ることができることを見出した。また、式(1)
で表されるβ−イミノアルコール類を還元することによ
り、式(4)で表される化合物に代表される式(3)で
表されるβ−アミノアルコール類を容易に得ることがで
きることを見出し、本発明を完成するに至った。Means for Solving the Problems In order to solve the above problems, the present inventors have studied the kinetic optical resolution of β-imino alcohols represented by the formula (1) using lipase which is a hydrolase. By conducting a study and hydrolyzing the compound represented by the formula (2) using lipase, it is possible to easily obtain the β-imino alcohol represented by the formula (1) with high optical purity. I found it. Equation (1)
That β-amino alcohols represented by the formula (3) represented by the compound represented by the formula (4) can be easily obtained by reducing the β-imino alcohols represented by the formula: Thus, the present invention has been completed.
【0013】すなわち、本発明は第1に、式(2)That is, the present invention firstly provides an equation (2)
【0014】[0014]
【化14】 Embedded image
【0015】(式中、R1は、炭素数1〜6のアルキル
基または炭素数7〜20のアラルキル基を表し、R
2は、炭素数1〜6のアルキル基、炭素数7〜20のア
ラルキル基または炭素数1〜6のハロアルキル基を表
し、R3は、炭素数1〜6のアルキル基または炭素数7
〜20のアラルキル基を表し、R4は、水素原子、炭素
数1〜6のアルキル基またはトリメチルシリル基を表
す。)で表される化合物をリパーゼを用いて加水分解す
る工程を有する、式(1)(Wherein R 1 represents an alkyl group having 1 to 6 carbon atoms or an aralkyl group having 7 to 20 carbon atoms;
2 represents an alkyl group having 1 to 6 carbon atoms, an aralkyl group having 7 to 20 carbon atoms or a haloalkyl group having 1 to 6 carbon atoms, and R 3 represents an alkyl group having 1 to 6 carbon atoms or 7 carbon atoms.
-20 represents an aralkyl group, and R 4 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or a trimethylsilyl group. Formula (1) having a step of hydrolyzing the compound represented by the formula (1) using a lipase.
【0016】[0016]
【化15】 Embedded image
【0017】(式中、R1、R2およびR4は、前記と同
じ意味を表す。)で表される光学活性β−イミノアルコ
ールの製造方法を提供する。本発明は第2に、前記式
(1)で表される光学活性β−イミノアルコールを還元
する工程を有する、式(3)(Wherein, R 1 , R 2 and R 4 have the same meanings as described above). The present invention secondly comprises a step of reducing the optically active β-imino alcohol represented by the formula (1),
【0018】[0018]
【化16】 Embedded image
【0019】(式中、R1、R2およびR4は前記と同じ
意味を表す。)で表される光学活性β−アミノアルコー
ル化合物の製造方法を提供する。(Wherein, R 1 , R 2 and R 4 have the same meanings as described above).
【0020】また、本発明は第3に、前記式(2)で表
される化合物および前記式(1)で表される化合物を提
供する。The present invention thirdly provides a compound represented by the formula (2) and a compound represented by the formula (1).
【0021】さらに、本発明は第4に、前記(2)で表
される化合物の製造中間体である、式(9)Further, the present invention fourthly provides a compound (9) which is an intermediate for producing the compound represented by the above (2).
【0022】[0022]
【化17】 Embedded image
【0023】(式中、R1及びR2は、前記と同じ意味を
表す。)で表される化合物を提供する。前記式(1)、
(2)および(9)で表される化合物は新規物質であ
る。(Wherein R 1 and R 2 have the same meanings as described above). Equation (1),
The compounds represented by (2) and (9) are new substances.
【0024】[0024]
【発明の実施の形態】以下、本発明を詳細に説明する。
前記式(9)および式(2)において、R1、R3はそれ
ぞれ独立して、メチル基、エチル基、n−プロピル基、
イソプロピル基、n−ブチル基、sec−ブチル基、t
−ブチル基、n−ペンチル基、n−ヘキシル基などの直
鎖もしくは分岐の炭素数1〜6のアルキル基、または、
ベンジル、α−メチルベンジル基、α、α−ジメチルベ
ンジル基、フェネチル基、3−フェニルプロピル基、4
−フェニル−n−ブチル基などの直鎖もしくは分岐の炭
素数7〜20のアラルキル基を表す。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail.
In the formulas (9) and (2), R 1 and R 3 are each independently a methyl group, an ethyl group, an n-propyl group,
Isopropyl group, n-butyl group, sec-butyl group, t
-Butyl group, n-pentyl group, linear or branched alkyl group having 1 to 6 carbon atoms such as n-hexyl group, or
Benzyl, α-methylbenzyl, α, α-dimethylbenzyl, phenethyl, 3-phenylpropyl, 4
-Represents a linear or branched aralkyl group having 7 to 20 carbon atoms such as -phenyl-n-butyl group.
【0025】前記アラルキル基は、ベンゼン環の任意の
位置に置換基を有していてもよい。かかる置換基として
は、ニトロ基、フッ素、塩素、臭素などのハロゲン原
子、メチル基、エチル基などのアルキル基、メトキシ
基、エトキシ基、プロポキシ基、イソプロポキシ基など
のアルコキシ基などが挙げられる。また、前記アラルキ
ル基は、同一または相異なる複数の置換基を有していて
もよい。The aralkyl group may have a substituent at any position on the benzene ring. Examples of such a substituent include a halogen atom such as nitro group, fluorine, chlorine and bromine; an alkyl group such as methyl group and ethyl group; and an alkoxy group such as methoxy group, ethoxy group, propoxy group and isopropoxy group. Further, the aralkyl group may have a plurality of the same or different substituents.
【0026】R2は、メチル基、エチル基、n−プロピ
ル基、イソプロピル基、n−ブチル基、sec−ブチル
基、t−ブチル基、n−ペンチル基、n−ヘキシル基な
どの直鎖もしくは分岐の炭素数1〜6のアルキル基、ベ
ンジル、α−メチルベンジル基、α、α−ジメチルベン
ジル基、フェネチル基、3−フェニルプロピル基、4−
フェニル−n−ブチル基などの直鎖もしくは分岐の炭素
数7〜20のアラルキル基、または、R 2 represents a linear or linear group such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, t-butyl, n-pentyl and n-hexyl. Branched alkyl group having 1 to 6 carbon atoms, benzyl, α-methylbenzyl group, α, α-dimethylbenzyl group, phenethyl group, 3-phenylpropyl group, 4-
A linear or branched aralkyl group having 7 to 20 carbon atoms such as a phenyl-n-butyl group, or
【0027】クロロメチル基、ジクロロメチル基、トリ
クロロメチル基、フルオロメチル基、ジフルオロメチル
基、トリフルオロメチル基、ブロモメチル基、ジブロモ
メチル基、トリブロモメチル基、2,2,2−トリクロ
ロエチル基、ペンタクロロエチル基、2,2,2−トリ
フルオロエチル基、ペンタフルオロエチル基、2,2,
2−トリブロモエチル基、ペンタブロモエチル基などの
炭素数1〜6のハロアルキル基を表す。Chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, bromomethyl, dibromomethyl, tribromomethyl, 2,2,2-trichloroethyl, Pentachloroethyl group, 2,2,2-trifluoroethyl group, pentafluoroethyl group, 2,2,2
Represents a haloalkyl group having 1 to 6 carbon atoms such as a 2-tribromoethyl group and a pentabromoethyl group.
【0028】また前記R2のアラルキル基は、ベンゼン
環の任意の位置に、1または2以上の同一若しくは相異
なるニトロ基、フッ素、塩素、臭素などのハロゲン原
子、メチル基、エチル基などのアルキル基、メトキシ
基、エトキシ基、プロポキシ基、イソプロポキシ基など
のアルコキシ基などの置換基を有していてもよい。The aralkyl group for R 2 may be, at any position on the benzene ring, one or more identical or different nitro groups, halogen atoms such as fluorine, chlorine and bromine, and alkyl groups such as methyl and ethyl. It may have a substituent such as a group, an alkoxy group such as a methoxy group, an ethoxy group, a propoxy group and an isopropoxy group.
【0029】R4は、水素原子、メチル、エチル、プロ
ピル、イソプロピル、n−ブチル、sec−ブチル、t
−ブチル、n−ペンチル、n−ヘキシルなどの炭素数1
〜6もアルキル基、またはトリメチルシリル基を表す。R 4 is a hydrogen atom, methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, t
1 carbon atom such as -butyl, n-pentyl, n-hexyl
To 6 also represent an alkyl group or a trimethylsilyl group.
【0030】式(9)および式(2)で表される化合物
は、例えば次のようにして製造することができる。The compounds represented by the formulas (9) and (2) can be produced, for example, as follows.
【0031】[0031]
【化18】 Embedded image
【0032】(式中、R1、R2、R3およびR4は前記と
同じ意味を表し、rは、メチル、エチル、プロピル、イ
ソプロピルなどの低級アルキル基を表す。) 先ず、原料となるカルボン酸エステル(5)に、式
(6)で表される1,3−ジチアンの2−リチウム塩を
作用させて、式(7)で表される化合物を得る。(In the formula, R 1 , R 2 , R 3 and R 4 have the same meanings as described above, and r represents a lower alkyl group such as methyl, ethyl, propyl and isopropyl.) A compound represented by the formula (7) is obtained by reacting the carboxylic acid ester (5) with a 2-lithium salt of 1,3-dithiane represented by the formula (6).
【0033】式(6)で表される1,3−ジチアンの2
−リチウム塩は、例えば、1,3−ジチアンに、n−ブ
チルリチウム、sec−ブチルリチウム、t−ブチルリ
チウムなどの有機リチウム、リチウム N,N−ジイソ
プロピルアミド(LDA)、リチウム ヘキサメチルジ
シラジドなどのリチウムアミド類などを作用させること
により調製することができる。有機リチウムあるいはリ
チウムアミド類の使用量は、1,3−ジチアン1モルに
対し、1.0〜1.5当量程度である。なお、式(6)
で表されるリチウム塩は、一般的に不安定であるので、
溶液状態で次の反応に使用するのが好ましい。The 1,3-dithiane 2 represented by the formula (6)
-Lithium salt is, for example, 1,3-dithiane, organic lithium such as n-butyllithium, sec-butyllithium, t-butyllithium, lithium N, N-diisopropylamide (LDA), lithium hexamethyldisilazide It can be prepared by reacting a lithium amide or the like. The amount of the organic lithium or lithium amide used is about 1.0 to 1.5 equivalents per 1 mol of 1,3-dithiane. Equation (6)
Since the lithium salt represented by is generally unstable,
It is preferred to use the solution in the next reaction.
【0034】式(6)で表されるリチウム塩を得る際に
用いられる溶媒としては、不活性溶媒、例えば、テトラ
ヒドロフラン(THF)、ジエチルエーテル、1,3−
ジメトキシエタンなどのエーテル系溶媒、n−ペンタ
ン、n−ヘキサンなどの飽和炭化水素類、ベンゼン、ト
ルエン、キシレンなどの芳香族炭化水素類などの1種も
しくはこれら2種以上の混合溶媒が挙げられる。反応
は、通常−100℃〜0℃の温度範囲で行われる。As a solvent used for obtaining the lithium salt represented by the formula (6), an inert solvent such as tetrahydrofuran (THF), diethyl ether, 1,3-
One or a mixture of two or more of ether solvents such as dimethoxyethane, saturated hydrocarbons such as n-pentane and n-hexane, and aromatic hydrocarbons such as benzene, toluene and xylene. The reaction is usually performed in a temperature range of -100C to 0C.
【0035】式(5)で表されるエステルと式(6)で
表されるリチウム塩を作用させる反応に用いられる溶媒
としては、不活性溶媒、例えば、テトラヒドロフラン
(THF)、ジエチルエーテル、1,3−ジメトキシエ
タンなどのエーテル系溶媒、n−ペンタン、n−ヘキサ
ンなどの飽和炭化水素類、ベンゼン、トルエン、キシレ
ンなどの芳香族炭化水素類などの1種若しくはこれら2
種以上の混合溶媒が挙げられる。この場合には、式
(6)で表されるリチウム塩の溶媒と同じ溶媒を用いる
のが好ましい。反応は、通常−100℃〜0℃の温度範
囲で行われる。式(6)で表される化合物の使用量は、
通常、式(5)で表される化合物1モルに対し、1〜2
当量である。Examples of the solvent used for the reaction of the ester represented by the formula (5) with the lithium salt represented by the formula (6) include inert solvents such as tetrahydrofuran (THF), diethyl ether, One or more of ether solvents such as 3-dimethoxyethane, saturated hydrocarbons such as n-pentane and n-hexane, and aromatic hydrocarbons such as benzene, toluene and xylene;
A mixed solvent of at least one kind is exemplified. In this case, it is preferable to use the same solvent as the solvent of the lithium salt represented by the formula (6). The reaction is usually performed in a temperature range of -100C to 0C. The amount of the compound represented by the formula (6) is
Usually, 1 to 2 relative to 1 mole of the compound represented by the formula (5)
Is equivalent.
【0036】次いで、式(7)で表される化合物に、式
(8):R1ONH2(式中、R1は前記と同じ意味を表
す。)で表されるアルコキシアミンを作用させることに
より、式(9)で表される化合物を得ることができる。Then, an alkoxyamine represented by the formula (8): R 1 ONH 2 (where R 1 has the same meaning as described above) acts on the compound represented by the formula (7). As a result, a compound represented by the formula (9) can be obtained.
【0037】またこの反応においては、式(8)で表さ
れるアルコキシアミンの塩を反応系に加えて、塩基を用
いて反応系内でアルコキシアミンを遊離の形として、式
(7)で表される化合物と反応させることもできる。か
かるアルコキシアミンの塩としては、塩酸塩や硫酸塩な
どが挙げられる。また、用いられる塩基としては、トリ
エチルアミン、ジイソプロピルエチルアミン、ピリジ
ン、ピペリジン、DBU(1,8−ジアザビシクロ
[5.4.0]ウンデ−7−セン)、DABCO(1,
4−ジアザビシクロ[2.2.2]オクタン)などの有
機塩基、ナトリウムメトキシド、ナトリウムエトキシド
などの金属アルコキシドなどが挙げられる。In this reaction, a salt of an alkoxyamine represented by the formula (8) is added to the reaction system, and the alkoxyamine is converted into a free form in the reaction system using a base. With the compound to be prepared. Examples of such an alkoxyamine salt include a hydrochloride and a sulfate. Examples of the base used include triethylamine, diisopropylethylamine, pyridine, piperidine, DBU (1,8-diazabicyclo [5.4.0] unde-7-cene), DABCO (1,
Organic bases such as 4-diazabicyclo [2.2.2] octane) and metal alkoxides such as sodium methoxide and sodium ethoxide.
【0038】この反応に用いられる溶媒としては、水、
メチルアルコール、エチルアルコール、n−プロピルア
ルコール、イソプロピルアルコールなどのアルコール
類、THF、ジエチルエーテル、1,3−ジメトキシエ
タンなどのエーテル系溶媒、塩化メチレン、クロロホル
ム、四塩化炭素などのハロゲン化炭化水素類、ベンゼ
ン、トルエン、キシレンなどの芳香族炭化水素類、n−
ヘキサン、n−ペンタンなどの脂肪族炭化水素類、N,
N−ジメチルホルムアミド、ジメチルスルホキシド、ア
セトニトリルなどの1種若しくはこれらの2種以上の混
合溶媒が挙げられる。As a solvent used in this reaction, water,
Alcohols such as methyl alcohol, ethyl alcohol, n-propyl alcohol and isopropyl alcohol; ether solvents such as THF, diethyl ether and 1,3-dimethoxyethane; halogenated hydrocarbons such as methylene chloride, chloroform and carbon tetrachloride , Aromatic hydrocarbons such as benzene, toluene and xylene, n-
Aliphatic hydrocarbons such as hexane and n-pentane;
One kind of N-dimethylformamide, dimethylsulfoxide, acetonitrile and the like, or a mixed solvent of two or more kinds of these may be used.
【0039】反応は、室温から用いられる溶媒の沸点ま
での温度範囲で円滑に進行する。この反応により得られ
る式(9)で表される化合物は、通常、炭素−窒素間の
二重結合に由来する2種類の立体異性体が得られる(以
下、このものから誘導される化合物はすべてこの種の立
体異性体が存在するが、これらはすべて本発明の範囲に
含まれる。)。式(9)で表される化合物の例を下記第
1表に示す。The reaction proceeds smoothly in a temperature range from room temperature to the boiling point of the solvent used. In the compound represented by the formula (9) obtained by this reaction, two types of stereoisomers derived from a carbon-nitrogen double bond are usually obtained (hereinafter, compounds derived from this compound are all There are stereoisomers of this kind, all of which are included in the scope of the present invention.) Examples of the compound represented by the formula (9) are shown in Table 1 below.
【0040】[0040]
【表1】 [Table 1]
【0041】次いで、式(9)で表される化合物の1,
3−ジチアン−2−イル基をアルデヒド基に変換するこ
とにより、式(10)で表される化合物を得る。この反
応は、塩基の存在下に水銀化合物を作用させることによ
り行うことができる。Next, one of the compounds represented by the formula (9)
By converting the 3-dithian-2-yl group to an aldehyde group, a compound represented by the formula (10) is obtained. This reaction can be performed by reacting a mercury compound in the presence of a base.
【0042】この反応に用いられる水銀化合物として
は、例えば過塩素酸水銀などが挙げられる。塩基として
は、炭酸カルシウム、炭酸カリウム、炭酸ナトリウムな
どの炭酸塩が挙げられる。水銀化合物の使用量は、式
(8)で表される化合物1モルに対し、通常1.5〜
3.0当量程度であり、塩基の使用量は、水銀化合物1
モルに対し、通常1.0〜2.0当量である。The mercury compound used in this reaction includes, for example, mercury perchlorate. Examples of the base include carbonates such as calcium carbonate, potassium carbonate, and sodium carbonate. The amount of the mercury compound to be used is usually 1.5 to 1 mol per mol of the compound represented by the formula (8).
It is about 3.0 equivalents, and the amount of the base used is
It is usually 1.0 to 2.0 equivalents per mol.
【0043】また、溶媒としては、THF、ジエチルエ
ーテル、1,3−ジメトキシエタンなどのエーテル系溶
媒と水との混合溶媒が挙げられる。反応は、通常、0℃
〜80℃の温度範囲で円滑に進行する。Examples of the solvent include a mixed solvent of water with an ether solvent such as THF, diethyl ether, and 1,3-dimethoxyethane. The reaction is usually performed at 0 ° C.
It proceeds smoothly in the temperature range of ~ 80 ° C.
【0044】次いで、式(10)で表されるアルデヒド
化合物に、式(11)で表されるアルキン類(置換基を
有していてもよいアセチレン)のアルカリ金属塩を反応
させることにより、式(12)で表される化合物を得る
ことができる。置換基を有していてもよいアセチレンと
しては、アセチレン、トリメチルシリルアセチレン、1
−プロピン、1−ブチン、1−ペンチン、1−ヘキシン
などが挙げられる。Next, the aldehyde compound represented by the formula (10) is reacted with an alkali metal salt of an alkyne represented by the formula (11) (acetylene which may have a substituent) to obtain a compound represented by the formula (11). The compound represented by (12) can be obtained. The acetylene which may have a substituent includes acetylene, trimethylsilylacetylene,
-Propyne, 1-butyne, 1-pentyne, 1-hexyne and the like.
【0045】式(11)で表される化合物は、例えば、
アセチレンまたはトリメチルシリルアセチレンに、金属
ナトリウム、金属リチウムなどのアルカリ金属、n−ブ
チルリチウム、sec−ブチルリチウム、t−ブチルリ
チウムなどの有機リチウムを反応させることによって得
ることができる。The compound represented by the formula (11) is, for example,
It can be obtained by reacting acetylene or trimethylsilylacetylene with an alkali metal such as sodium metal or metal lithium, or an organic lithium such as n-butyllithium, sec-butyllithium or t-butyllithium.
【0046】式(11)で表される化合物は、通常溶液
状態で反応に供される。式(11)で表される化合物の
使用量は、式(10)で表される化合物1モルに対し、
通常1.0〜1.5モル当量である。The compound represented by the formula (11) is usually subjected to the reaction in a solution state. The amount of the compound represented by the formula (11) is based on 1 mol of the compound represented by the formula (10).
Usually 1.0 to 1.5 molar equivalents.
【0047】この反応に用いられる溶媒としては、不活
性溶媒、例えば、THF、ジエチルエーテル、1,3−
ジメトキシエタンなどのエーテル系溶媒、n−ペンタ
ン、n−ヘキサンなどの飽和炭化水素類、ベンゼン、ト
ルエン、キシレンなどの芳香族炭化水素類などの1種も
しくはこれら2種以上の混合溶媒が挙げられる。反応
は、通常−100℃〜0℃の温度範囲で円滑に進行す
る。As a solvent used in this reaction, an inert solvent such as THF, diethyl ether, 1,3-
One or a mixture of two or more of ether solvents such as dimethoxyethane, saturated hydrocarbons such as n-pentane and n-hexane, and aromatic hydrocarbons such as benzene, toluene and xylene. The reaction usually proceeds smoothly in a temperature range of -100 ° C to 0 ° C.
【0048】次に、式(12)で表される化合物を塩基
の存在下にアシル化剤を作用させることにより、式
(2)で表される化合物を得ることができる。アシル化
剤としては、式:R3C(=O)Xあるいは(R3CO)
2O(式中、R3は前記と同じ意味を表し、Xはハロゲン
原子を表す。)が挙げられる。アシル化剤の使用量は、
式(12)で表される化合物1モルに対し、通常1.0
〜1.5モル当量である。Next, by reacting the compound represented by the formula (12) with an acylating agent in the presence of a base, the compound represented by the formula (2) can be obtained. As the acylating agent, R 3 C (= O) X or (R 3 CO)
2 O (wherein, R 3 has the same meaning as described above, and X represents a halogen atom). The amount of the acylating agent used is
Usually 1.0 mol per 1 mol of the compound represented by the formula (12).
1.51.5 molar equivalents.
【0049】用いられる塩基としては、トリエチルアミ
ン、ジイソプロピルエチルアミン、ピリジン、ピペリジ
ン、DBU、DABCOなどの有機塩基が挙げられる。
塩基の使用量は、前記アシル化剤1モルに対し、通常、
1.0〜1.5モル当量である。Examples of the base used include organic bases such as triethylamine, diisopropylethylamine, pyridine, piperidine, DBU and DABCO.
The amount of the base used is usually
1.0 to 1.5 molar equivalents.
【0050】また、式(12)で表される化合物のう
ち、R4がトリメチルシリル基の化合物は、脱シリル化
剤を作用させることにより、トリメチルシリル基が水素
原子に変換された、式(12)(R4=H)で表される
化合物を得ることができる。脱シリル化剤としては、例
えば、フッ素、フッ化カリウム、テトラブチルアンモニ
ウムフロライド(TBAF)などのフッ化アンモニウム
塩などが挙げられる。脱シリル化剤の使用量は、式(1
2)(R4=SiMe3)で表される化合物1モルに対
し、通常1.0〜2.0モル当量程度である。Among the compounds represented by the formula (12), those in which R 4 is a trimethylsilyl group have the formula (12) in which the trimethylsilyl group is converted into a hydrogen atom by the action of a desilylating agent. The compound represented by (R 4 = H) can be obtained. Examples of the desilylation agent include fluorine, potassium fluoride, ammonium fluoride salts such as tetrabutylammonium fluoride (TBAF), and the like. The amount of the desilylating agent used is determined by the formula (1)
2) It is usually about 1.0 to 2.0 molar equivalents per 1 mol of the compound represented by (R 4 = SiMe 3 ).
【0051】この反応に用いられる溶媒としては、不活
性溶媒、例えば、THF、ジエチルエーテル、1,3−
ジメトキシエタンなどのエーテル系溶媒などが挙げられ
る。反応は、通常、0℃〜80℃の温度範囲で円滑に進
行する。As a solvent used in this reaction, an inert solvent such as THF, diethyl ether, 1,3-
Examples include ether solvents such as dimethoxyethane. The reaction usually proceeds smoothly in a temperature range of 0 ° C to 80 ° C.
【0052】以上のようにして得られる式(2)で表さ
れる化合物の例を、下記第2表に示す。Examples of the compound represented by the formula (2) obtained as described above are shown in Table 2 below.
【0053】[0053]
【表2】 [Table 2]
【0054】次に、式(2)で表される化合物をリパー
ゼを用いて加水分解させることにより、式(1)で表さ
れるアルコール化合物を得ることができる。Next, by hydrolyzing the compound represented by the formula (2) using lipase, an alcohol compound represented by the formula (1) can be obtained.
【0055】[0055]
【化19】 Embedded image
【0056】この反応に用いられるリパーゼは、脂肪酸
のグリセリンエステルである脂肪の加水分解反応を触媒
する酵素であり、動植物および微生物に広く存在する酵
素である。リパーゼの種類により、基質特異性、作用最
適pH、最適温度などが異なる。本発明においては、式
(2)で表される化合物のアシル基(R3CO−)部分
を加水分解する能力を有するリパーゼを選択して使用す
る。かかるリパーゼとしては、リパーゼPSなどが挙げ
られる。このものは、凍結乾燥したものが市販されてお
り、そのまま本発明に使用することができる。リパーゼ
は、少なくとも加水分解反応を完結するだけの量が必要
であるが、その使用量は、反応系により適宜設定するこ
とができる。The lipase used in this reaction is an enzyme that catalyzes a hydrolysis reaction of a fat, which is a glycerin ester of a fatty acid, and is an enzyme widely present in animals, plants and microorganisms. Depending on the type of lipase, substrate specificity, optimal pH for action, optimal temperature, and the like differ. In the present invention, selected and used lipase having acyl group (R 3 CO-) partially hydrolyzing ability of the compound represented by formula (2). Such lipases include lipase PS and the like. This product is commercially available as a freeze-dried product, and can be used as it is in the present invention. The amount of lipase required is at least enough to complete the hydrolysis reaction, and the amount used can be appropriately set depending on the reaction system.
【0057】またリパーゼは、前述したように、最も加
水分解の触媒活性を発現する最適pH(通常、pH=6
〜8付近)がある。従って、反応系が最適pHになるよ
うに、反応系に緩衝溶液を用いるのが好ましい。緩衝溶
液としては、リン酸二水素カリウム+水酸化ナトリウ
ム、リン酸水素二カリウム+リン酸水素二ナトリウム、
フタル酸水素カリウム+水酸化ナトリウム、ホウ酸+塩
化カリウム+水酸化ナトリウム、ホウ砂+水酸化ナトリ
ウム、リン酸二ナトリウム+クエン酸などが挙げられ
る。これらのうち、リン酸塩を含む緩衝溶液の使用が好
ましい。As described above, the lipase has an optimum pH (usually pH = 6) at which the catalytic activity of hydrolysis is exhibited.
~ 8). Therefore, it is preferable to use a buffer solution in the reaction system so that the reaction system has an optimum pH. As the buffer solution, potassium dihydrogen phosphate + sodium hydroxide, dipotassium hydrogen phosphate + disodium hydrogen phosphate,
Examples include potassium hydrogen phthalate + sodium hydroxide, boric acid + potassium chloride + sodium hydroxide, borax + sodium hydroxide, disodium phosphate + citric acid, and the like. Of these, the use of a buffer solution containing phosphate is preferred.
【0058】この反応に用いられる溶媒としては、例え
ば、水とTHF、アセトニトリルなどの水と相溶性のあ
る有機溶媒との混合溶媒が挙げられる。反応は、室温〜
50℃の温度範囲で円滑に進行し、数時間から〜数百時
間で完結する。Examples of the solvent used in this reaction include a mixed solvent of water and an organic solvent compatible with water such as THF and acetonitrile. Reaction is at room temperature
It proceeds smoothly in a temperature range of 50 ° C. and is completed in several hours to several hundred hours.
【0059】この反応は立体選択的である。式(2)で
表される化合物は、アシルオキシ基(R3COO−基)
に結合する不斉炭素原子に由来する2種類の光学異性体
が存在する。リパーゼは、この2種類の光学異性体のう
ち、一方の異性体の加水分解反応のみを選択的に進行せ
しめる(速度論的光学分割)。反応液には、加水分解生
成物と未加水分解物とが存在するが、加水分解生成物の
みを通常の有機合成化学的分離手段により、単離精製す
ることができる。なお、未加水分解物はラセミ化させ
て、再度加水分解反応に供することができる。This reaction is stereoselective. The compound represented by the formula (2) is an acyloxy group (R 3 COO— group)
There are two types of optical isomers derived from the asymmetric carbon atom bonded to. Lipase selectively proceeds only the hydrolysis reaction of one of the two optical isomers (kinetic optical resolution). The reaction solution contains a hydrolysis product and an unhydrolysed product, and only the hydrolysis product can be isolated and purified by ordinary organic synthetic chemical separation means. The unhydrolyzed product can be racemized and then subjected to the hydrolysis reaction again.
【0060】以上にようにして得られる式(1)で表さ
れる化合物の例を、下記第3表に示す。Examples of the compound represented by the formula (1) obtained as described above are shown in Table 3 below.
【0061】[0061]
【表3】 [Table 3]
【0062】次いで、得られた式(1)で表される化合
物を還元剤により還元して、式(3)で表されるβ−ア
ミノアルコール化合物に誘導することができる。Next, the obtained compound represented by the formula (1) can be reduced with a reducing agent to obtain a β-amino alcohol compound represented by the formula (3).
【0063】[0063]
【化20】 Embedded image
【0064】還元剤としては、Na[Al(CH3OC
H2CH2O)2H2](VITRIDE)、ジイソブチル
アルミニウムハイドライドなどの水素化アルミニウム類
などを用いることができる。反応溶媒としては、不活性
溶媒、例えば、THF、ジエチルエーテル、1,3−ジ
メトキシエタンなどのエーテル系溶媒などが挙げられ
る。反応は、通常、−100℃〜0℃の温度範囲で円滑
に進行する。As a reducing agent, Na [Al (CH 3 OC)
H 2 CH 2 O) 2 H 2] (VITRIDE), such as aluminum hydride such as diisobutyl aluminum hydride can be used. Examples of the reaction solvent include inert solvents, for example, ether solvents such as THF, diethyl ether, and 1,3-dimethoxyethane. The reaction usually proceeds smoothly in a temperature range of -100 ° C to 0 ° C.
【0065】また、式(3)で表される化合物は、式
(1)で表される化合物にオクタカルボニルジコバルト
を反応させて三重結合を保護した後、炭素−窒素二重結
合を選択的に還元して得ることもできる(下記参照。)Further, the compound represented by the formula (3) is prepared by reacting the compound represented by the formula (1) with octacarbonyldicobalt to protect the triple bond and then selectively form the carbon-nitrogen double bond. (See below).
【0066】[0066]
【化21】 Embedded image
【0067】なお、式(1)で表される化合物のうち、
R4がトリメチルシリル基である化合物(1、R4=Si
Me3)は、脱シリル化剤を用いて式(1、R4=H)で
表される化合物へ導くことができる。脱シリル化剤とし
ては、前記で列記したものと同様なものを用いることが
できる。Incidentally, among the compounds represented by the formula (1),
Compounds in which R 4 is a trimethylsilyl group (1, R 4 = Si
Me 3 ) can be converted to a compound represented by the formula (1, R 4 = H) using a desilylating agent. As the desilylation agent, those similar to those listed above can be used.
【0068】以上のようにして得られるβ−アミノアル
コール類の例を、下記第4表に示す。Examples of β-amino alcohols obtained as described above are shown in Table 4 below.
【0069】[0069]
【表4】 [Table 4]
【0070】次いで、得られた式(3)で表される化合
物のうち、R2がベンジル基(Bn基)である化合物
は、例えば、以下に示すようにして、α−ヒドロキシ−
β−アミノ酸誘導体(15)に誘導することができる。Next, among the obtained compounds represented by the formula (3), those in which R 2 is a benzyl group (Bn group) are, for example, as follows:
β-amino acid derivative (15) can be derived.
【0071】[0071]
【化22】 Embedded image
【0072】(式中、R1は前記と同じ意味を表し、
r’は低級アルキル基を表す。)式(15)で表される
化合物は、前記式(16)で表される抗エイズ薬(プロ
テアーゼ阻害剤)の製造中間体として有用である。(Wherein, R 1 has the same meaning as described above;
r ′ represents a lower alkyl group. ) The compound represented by the formula (15) is useful as an intermediate for producing the anti-AIDS drug (protease inhibitor) represented by the formula (16).
【0073】[0073]
【実施例】次に、製造例および実施例により、本発明を
更に詳細に説明する。(製造例1)1−(1,3)ジチアジン−2−イル−2
−フェニルエタノン(7a)の合成 Next, the present invention will be described in more detail with reference to Production Examples and Examples. (Production Example 1) 1- (1,3) dithiazin-2-yl-2
Synthesis of -phenylethanone (7a)
【0074】[0074]
【化23】 Embedded image
【0075】アルゴン雰囲気下で、100mlのナス型
フラスコにフェニル酢酸エチル2.0g(0.012m
ol)のTHF25ml溶液に、別途調製した2−リチ
オ−1,3−ジチアンのTHF溶液25ml(0.01
2mol)を、−78℃でゆっくりと滴下し、さらに1
0分間攪拌した。反応液に、−78℃でメタノール、次
いで室温で2規定塩酸を加えることによって反応を停止
させた後、酢酸エチルで抽出を行い、有機層を無水硫酸
ナトリウムで乾燥させ、ろ過した。ろ液を減圧濃縮しし
て得られた粗生成物をシリカゲルクロマトグラフィー
(n−ヘキサン:酢酸エチル=15:1)にて単離精製
を行い、目的物(7a)1.48gを得た。収率51%In an argon atmosphere, 2.0 g of ethyl phenylacetate (0.012 m
ol) in 25 ml of THF was added to 25 ml of THF solution of 2-lithio-1,3-dithiane prepared separately (0.01 ml).
2 mol) was slowly added dropwise at -78 ° C.
Stirred for 0 minutes. The reaction was quenched by adding methanol at −78 ° C. and then 2N hydrochloric acid at room temperature, followed by extraction with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the crude product obtained was isolated and purified by silica gel chromatography (n-hexane: ethyl acetate = 15: 1) to obtain 1.48 g of the desired product (7a). Yield 51%
【0076】1H−NMR(CDCl3、δppm):
1.97−2.11(m,2H)、2.51−2.60
(m,2H)、3.19−3.29(m,2H)、3.
96(s,2H)、4.26(s,1H)、7.20−
7.34(m,5H) 1 H-NMR (CDCl 3 , δ ppm):
1.97-2.11 (m, 2H), 2.51-2.60
(M, 2H), 3.19-3.29 (m, 2H), 3.
96 (s, 2H), 4.26 (s, 1H), 7.20-
7.34 (m, 5H)
【0077】IR(neat,cm-1):1718,1
324,1263,1060,702IR (neat, cm -1 ): 1718,1
324,1263,1060,702
【0078】(実施例1)1−(1,3)ジチアン−2
−イル−2−フェニルエタノン O−ベンジルオキシム
(9a)の合成 Example 1 1- (1,3) dithiane-2
-Yl-2-phenylethanone O-benzyloxime
Synthesis of (9a)
【0079】[0079]
【化24】 Embedded image
【0080】アルゴン雰囲気下で、100mlの二口フ
ラスコに、先に得た(7a)26.2g(0.026m
ol)のメタノール90ml溶液を加え、次いで、ベン
ジルオキシアミン塩酸塩6.6g(0.042mol)
とピリジン4.5g(0.057mol)を加え、室温
で30分間攪拌した。反応液に飽和食塩水を加えること
によって反応を停止させた後、酢酸エチルで抽出した。
有機層を無水硫酸ナトリウムで乾燥し、ろ過し、ろ液を
減圧濃縮して粗生成物を得た。シリカゲルカラムクロマ
トグラフィー(n−ヘキサン:酢酸エチル=18:1)
により単離精製を行い、目的物(異性体1及び異性体2
の混合物)8.3gを得た。収率84%In an argon atmosphere, 26.2 g (0.026 m) of the previously obtained (7a) was placed in a 100 ml two-necked flask.
ol) in 90 ml of methanol and then 6.6 g (0.042 mol) of benzyloxyamine hydrochloride
And 4.5 g (0.057 mol) of pyridine were added, and the mixture was stirred at room temperature for 30 minutes. The reaction was quenched by adding saturated saline to the reaction solution, and extracted with ethyl acetate.
The organic layer was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to obtain a crude product. Silica gel column chromatography (n-hexane: ethyl acetate = 18: 1)
The desired product (isomer 1 and isomer 2)
8.3 g). 84% yield
【0081】異性体1の1H−NMR(CDCl3,δp
pm):1.78−2.07(m,2H)、2.67−
2.99(m,4H)、3.67(s、2H)、5.1
9(s、2H)、5.77(s、1H)、7.16−
7.37(m、10H) 1 H-NMR of isomer 1 (CDCl 3 , δp
pm): 1.78-2.07 (m, 2H), 2.67-
2.99 (m, 4H), 3.67 (s, 2H), 5.1
9 (s, 2H), 5.77 (s, 1H), 7.16-
7.37 (m, 10H)
【0082】異性体2の1H−NMR(CDCl3,δp
pm):1.78−2.07(m,2H)、2.67−
2.99(m,4H)、4.07(s,2H)、4.5
0(s,1H)、5.20(s,2H)、7.16−
7.37(m、10H) 1 H-NMR of isomer 2 (CDCl 3 , δp
pm): 1.78-2.07 (m, 2H), 2.67-
2.99 (m, 4H), 4.07 (s, 2H), 4.5
0 (s, 1H), 5.20 (s, 2H), 7.16-
7.37 (m, 10H)
【0083】IR(neat,cm-1):3002、1
743,1505,1463,1378,1263,1
225,1162,1041,701IR (neat, cm -1 ): 3002, 1
743, 1505, 1463, 1378, 1263, 1
225,1162,1041,701
【0084】(実施例2)1−(1,3)ジチアン−2
−イル−2−フェニルエタノン O−メチルオキシム
(9b)の合成 Example 2 1- (1,3) dithian-2
-Yl-2-phenylethanone O-methyloxime
Synthesis of (9b)
【0085】[0085]
【化25】 Embedded image
【0086】アルゴン雰囲気下で、50mlの二口フラ
スコに、先に得た(7a)250.1mg(1.051
mmol)のメタノール12.5ml溶液を加え、次い
で、メトキシアミン塩酸塩140.4mg(1.682
mmol)とピリジン182.9mg(2.312mm
ol)を加え、室温で1時間攪拌した。反応液に飽和食
塩水を加えることで反応を停止させた後、酢酸エチルで
抽出した。有機層を無水硫酸ナトリウムで乾燥しろ過
し、ろ液を減圧濃縮して得られた組生成物をシリカゲル
カラムクロマトグラフィー(n−ヘキサン:酢酸エチル
=20:1)により、単離精製を行い、目的物(異性体
1と異性体2の混合物)(9b)275.3mgを得
た。収率98%Under an argon atmosphere, 250.1 mg (1.051 mg) of (7a) obtained above was placed in a 50 ml two-necked flask.
mmol) in methanol (12.5 ml) and then add 140.4 mg (1.682 mg) of methoxyamine hydrochloride.
mmol) and 182.9 mg of pyridine (2.312 mm
ol) and stirred at room temperature for 1 hour. After the reaction was stopped by adding saturated saline to the reaction solution, the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The obtained product was isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 20: 1). 275.3 mg of the desired product (mixture of isomer 1 and isomer 2) (9b) was obtained. 98% yield
【0087】異性体1の1H−NMR(CDCl3,δp
pm):1.78−2.05(m,2H)、2.67−
2.95(m,4H)、3.66(s,2H)、3.9
2(s,3H)、5.71(s,1H)、7.18−
7.34(m,5H) 1 H-NMR of isomer 1 (CDCl 3 , δp
pm): 1.78-2.05 (m, 2H), 2.67-
2.95 (m, 4H), 3.66 (s, 2H), 3.9
2 (s, 3H), 5.71 (s, 1H), 7.18-
7.34 (m, 5H)
【0088】異性体2の1H−NMR(CDCl3,δp
pm):1.78−2.05(m,2H)、2.67−
2.95(m,4H)、3.84(s,2H)、3.9
4(s,3H)、4.55(s,1H)、7.18−
7.34(m,5H) 1 H-NMR of isomer 2 (CDCl 3 , δp
pm): 1.78-2.05 (m, 2H), 2.67-
2.95 (m, 4H), 3.84 (s, 2H), 3.9
4 (s, 3H), 4.55 (s, 1H), 7.18-
7.34 (m, 5H)
【0089】IR(neat,cm-1):3002,1
749,1500,1460,1270,1220,1
161,1044、703IR (neat, cm -1 ): 3002,1
749, 1500, 1460, 1270, 1220, 1
161, 1044, 703
【0090】(製造例2)2−ベンジルオキシイミノ−
3−フェニルプロピオンアルデヒド(10a)の合成 (Production Example 2) 2-benzyloxyimino-
Synthesis of 3-phenylpropionaldehyde (10a)
【0091】[0091]
【化26】 Embedded image
【0092】100mlのナス型フラスコに、先に得た
(9a)6.7g(0.018mol)のTHF−H2
Oの混合溶液(THF:H2O=5:1)60mlを加
え、次いで、炭酸カルシウム4.2g(0.042mo
l)を加えた後、過塩素酸水銀・6水和物19.6g
(0.038mol)の5.0ml水溶液をゆっくりと
滴下し、10分間攪拌した。反応液にエーテルを加え
て、セライトろ過を行い、ろ液を濃縮し、粗生成物を得
た。シリカゲルカラムクロマトグラフィー(n−ヘキサ
ン:酢酸エチル=20:1)により単離精製を行い、目
的物(異性体1および異性体2の混合物)(10a)
4.16gを得た。収率82%In a 100 ml eggplant-shaped flask, 6.7 g (0.018 mol) of the previously obtained (9a) THF-H 2 was added.
60 ml of a mixed solution of O (THF: H 2 O = 5: 1) was added, and then 4.2 g of calcium carbonate (0.042 mo).
1), 19.6 g of mercury perchlorate hexahydrate
(0.038 mol) of a 5.0 ml aqueous solution was slowly added dropwise, followed by stirring for 10 minutes. Ether was added to the reaction solution, the mixture was filtered through celite, and the filtrate was concentrated to obtain a crude product. It is isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 20: 1), and the desired product (mixture of isomer 1 and isomer 2) (10a)
4.16 g were obtained. 82% yield
【0093】異性体1の1H−NMR(CDCl3,δp
pm):3.80(s.2H)、5.34(s,2
H)、7.15−7.39(m,10H)、9.47
(s,1H) 1 H-NMR of isomer 1 (CDCl 3 , δp
pm): 3.80 (s. 2H), 5.34 (s, 2
H), 7.15-7.39 (m, 10H), 9.47
(S, 1H)
【0094】異性体2の1H−NMR(CDCl3,δp
pm):3.64(s,2H)、5.21(s,2
H)、7.15−7.39(m,10H)、10.28
(s,1H) 1 H-NMR of isomer 2 (CDCl 3 , δp
pm): 3.64 (s, 2H), 5.21 (s, 2
H), 7.15-7.39 (m, 10H), 10.28
(S, 1H)
【0095】IR(neat,cm-1):1710,1
223,1030,756,703IR (neat, cm -1 ): 1710,1
223,1030,756,703
【0096】(製造例3)2−メトキシイミノ−3−フ
ェニルプロピオンアルデヒド(10b)の合成 (Production Example 3) 2-methoxyimino-3-f
Synthesis of enylpropionaldehyde (10b)
【0097】[0097]
【化27】 Embedded image
【0098】100mlのナス型フラスコに、先に得た
(9b)3.4g(0.013mol)のTHF−H2
O混合溶液(THF:H2O=5:1)36mlを入
れ、炭酸カルシウム2.8g(0.028mol)を加
えた後、過塩素酸水銀6水和物13.2g(0.026
mol)の3.0ml水溶液をゆっくり滴下し、室温で
10分間攪拌した。反応液にジエチルエーテルを加えて
反応を停止させた後、セライトろ過して、ろ液を濃縮し
て粗生成物を得た。シリカゲルカラムクロマトグラフィ
ー(n−ヘキサン:酢酸エチル=20:1)により単離
精製を行い、(10b)2.0gを得た。収率89%In a 100 ml eggplant-shaped flask, 3.4 g (0.013 mol) of the previously obtained (9b) THF-H 2 was added.
After adding 36 ml of an O mixed solution (THF: H 2 O = 5: 1) and adding 2.8 g (0.028 mol) of calcium carbonate, 13.2 g (0.026 mol) of mercury perchlorate hexahydrate was added.
mol) was slowly added dropwise and stirred at room temperature for 10 minutes. After the reaction was stopped by adding diethyl ether to the reaction solution, the reaction solution was filtered through celite, and the filtrate was concentrated to obtain a crude product. Isolation and purification were performed by silica gel column chromatography (n-hexane: ethyl acetate = 20: 1) to obtain 2.0 g of (10b). 89% yield
【0099】異性体1の1H−NMR(CDCl3,δp
pm):3.65(s,2H)、4.14(s,3
H)、7.18−7.31(m,5H)、10.25
(s,1H) 1 H-NMR (CDCl 3 , δp
pm): 3.65 (s, 2H), 4.14 (s, 3
H), 7.18-7.31 (m, 5H), 10.25
(S, 1H)
【0100】異性体2の1H−NMR(CDCl3,δp
pm):3.78(s,2H)、4.00(s,3
H)、7.18−7.31(m,5H)、9.47
(s,1H) 1 H-NMR of isomer 2 (CDCl 3 , δp
pm): 3.78 (s, 2H), 4.00 (s, 3
H), 7.18-7.31 (m, 5H), 9.47
(S, 1H)
【0101】IR(neat,cm-1):1713,1
215,1027,701IR (neat, cm -1 ): 1713,1
215, 1027, 701
【0102】(実施例3)3−ヒドロキシ−1−フェニ
ル−5−トリメチルシリルペント−4−イン−2−オン
O−ベンジルオキシム(12a)の合成 Example 3 3-Hydroxy-1- phenyl
Ru-5-trimethylsilylpent-4-yn-2-one
Synthesis of O-benzyl oxime (12a)
【0103】[0103]
【化28】 Embedded image
【0104】アルゴン雰囲気下で、50mlの二口ナス
型フラスコにトリメチルシリルアセチレン640.0m
g(6.516mmol)のTHF5.0ml溶液を入
れ、そこへ、1.44Mのn−ブチルリチウムのヘキサ
ン溶液4.5ml(6.516mmol)を、−78℃
でゆっくりと滴下し、同温度で1時間攪拌した。そこ
へ、先に得た(10a)1.26g(4.344mmo
l)のTHF溶液(3.0ml)を−78度でゆっくり
と滴下し、同温度で30分間攪拌した。反応液に、−7
8℃でメタノール、室温で2規定塩酸を加えて反応を停
止させた。酢酸エチルで抽出し、有機層を無水硫酸ナト
リウムで乾燥し、ろ過した。ろ液を減圧濃縮して得られ
た粗生成物をシリカゲルカラムクロマトグラフィー(n
−ヘキサン:酢酸エチル=10:1)で分離精製して目
的物(トランス体:シス体=4.5:1の混合物)を
1.44g得た。収率85%Under an argon atmosphere, trimethylsilylacetylene (640.0 m) was placed in a 50 ml two-necked eggplant type flask.
g (6.516 mmol) in 5.0 ml of THF was added thereto, and 4.5 ml (6.516 mmol) of a 1.44 M solution of n-butyllithium in hexane was added thereto at -78 ° C.
, And the mixture was stirred at the same temperature for 1 hour. There, 1.26g (4.344mmo) of (10a) previously obtained.
l) A THF solution (3.0 ml) was slowly added dropwise at -78 ° C, and the mixture was stirred at the same temperature for 30 minutes. Add -7 to the reaction solution.
The reaction was stopped by adding methanol at 8 ° C and 2N hydrochloric acid at room temperature. The mixture was extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and filtered. The crude product obtained by concentrating the filtrate under reduced pressure was subjected to silica gel column chromatography (n
Separation and purification with -hexane: ethyl acetate = 10: 1) gave 1.44 g of the desired product (trans-isomer: cis-isomer = 4.5: 1 mixture). 85% yield
【0105】トランス体の1H−NMR(CDCl3,δ
ppm):0.00(s,9H)、3.02(d,J=
5.28Hz,1H)、3.52(d,J=14.52
Hz,1H)、3.90(d,J=14.52Hz,1
H)、4.76(d、J=5.28Hz,1H),5.
01(s,1H)、7.05−7.23(m,10H) 1 H-NMR (CDCl 3 , δ) of trans form
ppm): 0.00 (s, 9H), 3.02 (d, J =
5.28 Hz, 1 H), 3.52 (d, J = 14.52)
Hz, 1H), 3.90 (d, J = 14.52 Hz, 1
H), 4.76 (d, J = 5.28 Hz, 1H), 5.
01 (s, 1H), 7.05-7.23 (m, 10H)
【0106】シス体の1H−NMR(CDCl3,δpp
m):0.00(s,9H)、2.81(d,J=7.
26Hz,1H)、3.54(s,2H)、5.05
(s,2H)、5.17(d、J=7.26Hz,1
H)、7.05−7.23(m,10H) 1 H-NMR of cis form (CDCl 3 , δpp
m): 0.00 (s, 9H), 2.81 (d, J = 7.
26Hz, 1H), 3.54 (s, 2H), 5.05
(S, 2H), 5.17 (d, J = 7.26 Hz, 1
H), 7.05-7.23 (m, 10H).
【0107】IR(neat,cm-1):3400,3
010,1236,866,772IR (neat, cm -1 ): 3400,3
010,1236,866,772
【0108】(実施例4)3−ヒドロキシ−1−フェニ
ル−5−トリメチルシリルペント−4−イン−2−オン
O−メチルオキシム(12b)の合成 Example 4 3-Hydroxy-1- phenyl
Ru-5-trimethylsilylpent-4-yn-2-one
Synthesis of O-methyl oxime (12b)
【0109】[0109]
【化29】 Embedded image
【0110】アルゴン雰囲気下で、50mlのトリメチ
ルシリルアセチレン1.66g(0.017mol)を
加え、そこへ、1.44Mのn−ブチルリチウムのヘキ
サン溶液12ml(0.017mol)を−78℃でゆ
っくりと滴下し、同温度で1時間攪拌した。反応液に、
先に得た(10b)2.0g(0.011mol)のT
HF5mlを−78℃でゆっくりと滴下し、同温度で2
0分間攪拌した。−78℃でメタノール、室温で2規定
塩酸を加えることで反応を停止させた後、酢酸エチルで
抽出した。有機層を無水硫酸ナトリウムで乾燥したの
ち、溶媒を減圧留去して粗生成物を得た。このものをシ
リカゲルカラムクロマトグラフィー(n−ヘキサン:酢
酸エチル=10:1)により単離精製を行い、目的物
(12b)を2.6g得た。収率84%Under an argon atmosphere, 1.66 g (0.017 mol) of 50 ml of trimethylsilylacetylene was added, and 12 ml (0.017 mol) of a 1.44 M n-butyllithium hexane solution was slowly added at -78 ° C. The mixture was added dropwise and stirred at the same temperature for 1 hour. In the reaction solution,
2.0 g (0.011 mol) of T obtained previously (10b)
HF (5 ml) was slowly added dropwise at -78 ° C.
Stirred for 0 minutes. The reaction was stopped by adding methanol at −78 ° C. and 2N hydrochloric acid at room temperature, followed by extraction with ethyl acetate. After the organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure to obtain a crude product. This was isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 10: 1) to obtain 2.6 g of the desired product (12b). 84% yield
【0111】トランス体の1H−NMR(CDCl3,δ
ppm):0.00(s,9H)、3.02(d,J=
5.28Hz,1H)、3.52(d,J=14.52
Hz,1H)、3.90(d,J=14.52Hz,1
H)、4.76(d、J=5.28Hz,1H),5.
01(s,1H)、7.05−7.23(m,10H) 1 H-NMR (CDCl 3 , δ) of trans form
ppm): 0.00 (s, 9H), 3.02 (d, J =
5.28 Hz, 1 H), 3.52 (d, J = 14.52)
Hz, 1H), 3.90 (d, J = 14.52 Hz, 1
H), 4.76 (d, J = 5.28 Hz, 1H), 5.
01 (s, 1H), 7.05-7.23 (m, 10H)
【0112】シス体の1H−NMR(CDCl3,δpp
m):0.01(s,9H)、2.78(d,J=7.
26Hz,1H)、3.55(s,2H)、3.80
(s,3H)、5.18(d,J=7.26Hz)、
7.07−7.17(m,5H) 1 H-NMR of cis form (CDCl 3 , δpp
m): 0.01 (s, 9H), 2.78 (d, J = 7.
26Hz, 1H), 3.55 (s, 2H), 3.80
(S, 3H), 5.18 (d, J = 7.26 Hz),
7.07-7.17 (m, 5H)
【0113】IR(neat,cm-1):3400,3
000,2950,1227,1060,860IR (neat, cm -1 ): 3400,3
000,2950,1227,1060,860
【0114】(実施例5)3−ヒドロキシ−1−フェニ
ル−ペント−4−イン−2−オン O−ベンジルオキシ
ム(12c)の合成 Example 5 3-Hydroxy-1- phenyl
Le-pent-4-yn-2-one O-benzyloxy
Synthesis of the system (12c)
【0115】[0115]
【化30】 Embedded image
【0116】アルゴン雰囲気下に、50ml二口ナス型
フラスコに、先得た(12a)262.0mg(0.7
45mmol)のTHF3.0ml溶液を加え、0℃で
1.0MのTBAF(テトラブチルアンモニウムフロラ
イド)のTHF0.82ml(0.82mmol)をゆ
っくり滴下し、同温度で10分間滴下した。反応液に2
規定塩酸を加えて反応を呈しさせた後、酢酸エチルで抽
出した。有機層を無水硫酸ナトリウムで乾燥させ、ろ過
し、ろ液を減圧濃縮して粗生成物を得た。このものをシ
リカゲルカラムクロマトグラフィー(n−ヘキサン:酢
酸エチル=5:1)により、単離精製を行い(12c)
(トランス体:シス体の混合物)を193.0mgを得
た。収率93%Under an argon atmosphere, 262.0 mg (0.7%) of the previously obtained (12a) was placed in a 50 ml two-necked eggplant type flask.
45 mmol) in THF (3.0 ml) was added, and at 0 ° C., 1.0 M TBAF (tetrabutylammonium fluoride) in 0.82 ml (0.82 mmol) of THF was slowly added dropwise, followed by dropwise addition at the same temperature for 10 minutes. 2 in the reaction solution
After adding normal hydrochloric acid to cause a reaction, the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to obtain a crude product. This was isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 5: 1) (12c).
193.0 mg (mixture of trans-form: cis-form) was obtained. 93% yield
【0117】トランス体の1H−NMR(CDCl3,δ
ppm):2.49(d,J=2.31Hz,1H)、
3.29(d,J=5.61Hz,1H)、3.63
(d,J=14.52Hz,1H),4.08(d,J
=14.52Hz,1H)、4.88(dd,J=3.
3Hz,2.31Hz,1H)、5.14(s,2
H)、7.19−7.35(m,10H) 1 H-NMR (CDCl 3 , δ) of trans form
ppm): 2.49 (d, J = 2.31 Hz, 1H),
3.29 (d, J = 5.61 Hz, 1H), 3.63
(D, J = 14.52 Hz, 1H), 4.08 (d, J
= 14.52 Hz, 1H), 4.88 (dd, J = 3.
3 Hz, 2.31 Hz, 1 H), 5.14 (s, 2
H), 7.19-7.35 (m, 10H)
【0118】シス体の1H−NMR(CDCl3,δpp
m):2.39(d,J=2.31Hz,1H)、3.
11(d,J=7.92Hz,1H),3.66(s,
2H)、5.17(s,2H)、5.30(dd,J=
5.61Hz,2.31Hz,1H)、7.19−7.
35(m,10H) 1 H-NMR of cis form (CDCl 3 , δpp
m): 2.39 (d, J = 2.31 Hz, 1H);
11 (d, J = 7.92 Hz, 1H), 3.66 (s,
2H), 5.17 (s, 2H), 5.30 (dd, J =
5.61 Hz, 2.31 Hz, 1H), 7.19-7.
35 (m, 10H)
【0119】IR(neat,cm-1):2993,2
330,1222,767IR (neat, cm -1 ): 2993,2
330, 1222, 767
【0120】(実施例6)3−ヒドロキシ−1−フェニ
ルペント−4−イン−2−オン O−メチルオキシム
(12d)の合成 Example 6 3-Hydroxy-1- phenyl
Lupent-4-yn-2-one O-methyloxime
Synthesis of (12d)
【0121】[0121]
【化31】 Embedded image
【0122】アルゴン雰囲気下で、50mlの二口ナス
型フラスコに、先に得た(12b)578.0mg
(2.099mmol)のTHF5.0ml溶液を加
え、1.0MのTBAFのTHF溶液5.0mlを0℃
でゆっくり加え、同温度で10分間攪拌した。反応液に
2規定塩酸を加えることで反応を停止させた後、酢酸エ
チルで抽出した。有機層を無水硫酸ナトリウムで乾燥し
た後、ろ過し、ろ液を減圧濃縮して粗生成物を得た。こ
のものをシリカゲルカラムクロマトグラフィー(n−ヘ
キサン:酢酸エチル=5:1)で単離精製して目的物
(トランス体とシス体の混合物)(12d)362.0
mgを得た。収率91%In an argon atmosphere, 578.0 mg of the previously obtained (12b) was placed in a 50 ml two-necked eggplant type flask.
(2.099 mmol) in 5.0 ml of THF was added, and 5.0 ml of 1.0 M TBAF in THF was added at 0 ° C.
And slowly stirred at the same temperature for 10 minutes. The reaction was stopped by adding 2N hydrochloric acid to the reaction solution, and then extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to obtain a crude product. This was isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 5: 1) to obtain the desired product (mixture of trans-form and cis-form) (12d) 362.0
mg was obtained. 91% yield
【0123】トランス体の1H−NMR(CDCl3,δ
ppm):2.53(d,J=2.31Hz,1H)、
3.19(d,J=5.61Hz,1H)、3.60
(d,J=14.5Hz,1H)、3.95(s,3
H)、4.09(d,J=14.52Hz,1H)、
4.87(dd,J=3.63Hz,2.31Hz,1
H)、7.22−7.32(m,5H) 1 H-NMR (CDCl 3 , δ) of trans form
ppm): 2.53 (d, J = 2.31 Hz, 1H),
3.19 (d, J = 5.61 Hz, 1H), 3.60
(D, J = 14.5 Hz, 1H), 3.95 (s, 3
H), 4.09 (d, J = 14.52 Hz, 1H),
4.87 (dd, J = 3.63 Hz, 2.31 Hz, 1
H), 7.22-7.32 (m, 5H)
【0124】シス体の1H−NMR(CDCl3,δpp
m):2.44(d,J=1.98Hz,1H)、3.
02(d,J=7.92Hz,1H)、3.68(d,
J=2.97Hz,1H),3.96(s,3H)、
5.24(dd,J=5.93Hz,1.98Hz,1
H)、7.22−7.32(m,5H) 1 H-NMR (CDCl 3 , δpp
m): 2.44 (d, J = 1.98 Hz, 1H);
02 (d, J = 7.92 Hz, 1H), 3.68 (d,
J = 2.97 Hz, 1H), 3.96 (s, 3H),
5.24 (dd, J = 5.93 Hz, 1.98 Hz, 1
H), 7.22-7.32 (m, 5H)
【0125】IR(neat,cm-1):3000、1
230,770IR (neat, cm -1 ): 3000, 1
230,770
【0126】(実施例7)1−(1−ベンジルオキシイ
ミノ−2−フェニルエチル)プロピン−2−イル プロ
ピオネート(2a)の合成 Example 7 1- (1-benzyloxyi)
Mino-2-phenylethyl) propyn-2-ylpro
Synthesis of Pionate (2a)
【0127】[0127]
【化32】 Embedded image
【0128】アルゴン雰囲気下で,30mlの二口ナス
型フラスコに、先に得た(12c)88.0mg(0.
315mmol)の塩化メチレン2.0ml溶液を入
れ、そこへ、トリエチルアミン63.7mg(0.63
0mmol)と触媒量のDMAPを加え、プロピオニル
クロライド58.3mg(0.630mmol)をゆっ
くり滴下し、0℃で10分間攪拌した。反応液に飽和食
塩水を加えることで反応を停止させた後、酢酸エチルで
抽出し、有機層を無水硫酸ナトリウムで乾燥し、ろ過し
た。ろ液を減圧濃縮して得られた粗生成物をシリカゲル
カラムクロマトグラフィー(n−ヘキサン:酢酸エチル
=5:1)により単離精製して、(2a、トランス体及
びシス体の混合物)を100.1mg得た。収率95%Under an argon atmosphere, 88.0 mg (0.12 mg) of (12c) previously obtained was placed in a 30 ml two-necked eggplant type flask.
315 mmol) of methylene chloride in 2.0 ml was added thereto, and 63.7 mg (0.63 mg) of triethylamine was added thereto.
0 mmol) and a catalytic amount of DMAP were added, and 58.3 mg (0.630 mmol) of propionyl chloride was slowly added dropwise, followed by stirring at 0 ° C. for 10 minutes. After the reaction was stopped by adding a saturated saline solution to the reaction solution, extraction was performed with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate and filtered. The crude product obtained by concentrating the filtrate under reduced pressure was isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 5: 1) to give (2a, a mixture of trans and cis isomers). 0.1 mg was obtained. 95% yield
【0129】トランス体の1H−NMR(CDCl3,δ
ppm):0.99(t,J=7.59Hz,3H)、
1.96−2.24(m,2H)、2.54(d,J=
2.31Hz,1H)、3.71(d、J=14.52
Hz,1H)、4.00(d、J=14.52Hz,1
H)、5.17(s,2H)、5.99(d,J=1.
98Hz,1H)、7.15−7.37(m,5H) 1 H-NMR (CDCl 3 , δ) of trans form
ppm): 0.99 (t, J = 7.59 Hz, 3H),
1.96-2.24 (m, 2H), 2.54 (d, J =
2.31 Hz, 1H), 3.71 (d, J = 14.52)
Hz, 1H), 4.00 (d, J = 14.52 Hz, 1
H), 5.17 (s, 2H), 5.99 (d, J = 1.
98Hz, 1H), 7.15-7.37 (m, 5H)
【0130】シス体の1H−NMR(CDCl3,δpp
m):0.93(t,J=7.26Hz,3H)、1.
96−2.24(m,2H)、2.41(d,J=2.
31Hz,1H)、3.67(s,2H)、5.21
(s,2H)、6.72(d,J=2.31Hz,1
H)、7.15−7.37(m,5H) 1 H-NMR of cis form (CDCl 3 , δpp
m): 0.93 (t, J = 7.26 Hz, 3H);
96-2.24 (m, 2H), 2.41 (d, J = 2.
31 Hz, 1H), 3.67 (s, 2H), 5.21
(S, 2H), 6.72 (d, J = 2.31 Hz, 1
H), 7.15-7.37 (m, 5H)
【0131】IR(neat,cm-1):3250,3
000,2920,1760,1505,1463,1
370,1170,1030,703IR (neat, cm -1 ): 3250,3
000,2920,1760,1505,1463,1
370, 1170, 1030, 703
【0132】(実施例8)1−(1−メトキシイミノ−
2−フェニルエチル)プロピン−2−イル プロピオネ
ート(2b)の合成 Example 8 1- (1-Methoxyimino-
2-phenylethyl) propyn-2-yl propione
Synthesis of the plate (2b)
【0133】[0133]
【化33】 Embedded image
【0134】アルゴン雰囲気下に、30mlの二口ナス
型フラスコに、先に得た(12d)186.3mg
(0.917mmol)の塩化メチレン5.0ml溶液
を入れ、底へ、トリエチルアミン185.5mg(1.
833mmol)と触媒量のDMAPを加えた後、プロ
ピオニルクロライド169.6mg(1.833mmo
l)を0℃でゆっくり滴下し、同温度で10分間攪拌し
た。反応液に飽和食塩水を加えることで反応を停止させ
た後、酢酸エチルで抽出した。有機層を無水硫酸ナトリ
ウムで乾燥した後、ろ過し、ろ液を減圧濃縮し粗生成物
を得た。おのものをシリカゲルカラムクロマトグラフィ
ー(n−ヘキサン:酢酸エチル=5:1)で単離精製し
て目的物(トランス異性体とシス異性体の混合物)(2
b)227.0mgを得た。収率95%In an argon atmosphere, 186.3 mg of the previously obtained (12d) was placed in a 30 ml two-necked eggplant type flask.
(0.917 mmol) in 5.0 ml of methylene chloride was added to the bottom, and 185.5 mg of triethylamine (1.
After adding 833 mmol) and a catalytic amount of DMAP, 169.6 mg (1.833 mmol) of propionyl chloride were added.
1) was slowly added dropwise at 0 ° C., and the mixture was stirred at the same temperature for 10 minutes. After the reaction was stopped by adding saturated saline to the reaction solution, the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to obtain a crude product. Each product was isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 5: 1) to obtain the desired product (mixture of trans isomer and cis isomer) (2
b) 227.0 mg were obtained. 95% yield
【0135】トランス体の1H−NMR(CDCl3,δ
ppm):0.99(t,J=7.59Hz,3H)、
1.99−2.24(m,2H)、2.57(dd,J
=1.65Hz,0.66Hz,1H)、3.69
(d,J=14.52Hz,1H),3.96(s,3
H)、4.01(d,J=14.52Hz,1H)、
6.01(d,J=1.98Hz,1H)、7.20−
7.31(m,5H) 1 H-NMR of trans form (CDCl 3 , δ
ppm): 0.99 (t, J = 7.59 Hz, 3H),
1.99-2.24 (m, 2H), 2.57 (dd, J
= 1.65Hz, 0.66Hz, 1H), 3.69
(D, J = 14.52 Hz, 1H), 3.96 (s, 3
H), 4.01 (d, J = 14.52 Hz, 1H),
6.01 (d, J = 1.98 Hz, 1H), 7.20−
7.31 (m, 5H)
【0136】シス体の1H−NMR(CDCl3,δpp
m):0.93(t,J=7.26Hz,3H)、1.
99−2.24(m,2H),2.44(dd,J=
1.65Hz,0.66Hz,1H)、3.69(s,
2H)、3.98(s,3H)、6.68(d,J=
2.31Hz,1H)、7.20−7.31(m,5
H) 1 H-NMR of cis form (CDCl 3 , δpp
m): 0.93 (t, J = 7.26 Hz, 3H);
99-2.24 (m, 2H), 2.44 (dd, J =
1.65 Hz, 0.66 Hz, 1 H), 3.69 (s,
2H), 3.98 (s, 3H), 6.68 (d, J =
2.31 Hz, 1H), 7.20-7.31 (m, 5
H)
【0137】IR(neat,cm-1):3250,2
920,1765,1503,1463,1370,1
225,1178,1162,900,760,707IR (neat, cm -1 ): 3250,2
920, 1765, 1503, 1463, 1370, 1
225,1178,1162,900,760,707
【0138】(実施例9)1−(1−ベンジルオキシイ
ミノ−2−フェニルエチル)−3−トリメチルシリルプ
ロピン−2−イル アセテート(2c)の合成 Example 9 1- (1-benzyloxyi)
Mino-2-phenylethyl) -3-trimethylsilylp
Synthesis of lopin-2-yl acetate (2c)
【0139】[0139]
【化34】 Embedded image
【0140】アルゴン雰囲気下で、30mlの二口ナス
型フラスコに、先に得た(12a)66.7mg(0.
190mmol)の塩化メチレン2.0ml溶液を加
え、トリエチルアミン38.4mg(0.380mmo
l)と触媒量のDMAPを加えた後、アセチルクロライ
ド29.8mg(0.380mmol)を0℃でゆっく
りと滴下し、同温度で10分間攪拌した。反応液に飽和
食塩水を加えることで反応を停止させた後、酢酸エチル
で抽出した。有機層を無水硫酸ナトリウムで乾燥し、ろ
過した。ろ液を減圧濃縮して得られた粗生成物をシリカ
ゲルカラムクロマトグラフィー(n−ヘキサン:酢酸エ
チル=10:1)で単離精製を行い、目的物(トランス
体とシス体の混合物)70.0mgを得た。収率94%Under an argon atmosphere, 66.7 mg of the previously obtained (12a) (0.2 g) was placed in a 30 ml two-necked eggplant type flask.
190 mmol) in methylene chloride (2.0 ml) was added, and triethylamine (38.4 mg, 0.380 mmol) was added.
After 1) and a catalytic amount of DMAP were added, 29.8 mg (0.380 mmol) of acetyl chloride was slowly added dropwise at 0 ° C., and the mixture was stirred at the same temperature for 10 minutes. After the reaction was stopped by adding saturated saline to the reaction solution, the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the crude product obtained was isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 10: 1), and the desired product (mixture of trans-form and cis-form) was obtained. 0 mg was obtained. 94% yield
【0141】トランス体の1H−NMR(CDCl3,δ
ppm):0.00(s,9H)、1.75(s,3
H)、3.62(d,J=14.52Hz,1H)、
3.80(d,J=14.52Hz,1H)、5.02
(s,2H)、5.87(s,1H)、7.07−7.
19(m,10H) 1 H-NMR (CDCl 3 , δ) of trans form
ppm): 0.00 (s, 9H), 1.75 (s, 3)
H), 3.62 (d, J = 14.52 Hz, 1H),
3.80 (d, J = 14.52 Hz, 1H), 5.02
(S, 2H), 5.87 (s, 1H), 7.07-7.
19 (m, 10H)
【0142】シス体の1H−NMR(CDCl3,δpp
m):0.01(s,9H)、1.64(s,3H)、
3.51(s,2H)、5.09(s,2H)、6.5
9(s,1H)、7.07−7.19(m,10H) 1 H-NMR of cis form (CDCl 3 , δpp
m): 0.01 (s, 9H), 1.64 (s, 3H),
3.51 (s, 2H), 5.09 (s, 2H), 6.5
9 (s, 1H), 7.07-7.19 (m, 10H)
【0143】IR(neat,cm-1):3008,2
950,1765,1517,1471,1241,1
038,880,770,705IR (neat, cm -1 ): 3008, 2
950, 1765, 1517, 1471, 1241, 1
038,880,770,705
【0144】(実施例10)1−(1−メトキシイミノ
−2−フェニルエチル)−3−トリメチルシリルプロピ
ン−2−イル アセテート(2d)の合成 Example 10 1- (1-Methoxyimino)
-2-phenylethyl) -3-trimethylsilylpropyl
Synthesis of N-2-yl acetate (2d)
【0145】[0145]
【化35】 Embedded image
【0146】アルゴン雰囲気下で、30mlの二口ナス
型フラスコに、先に得た(12b)331.6mg
(1.204mmol)の塩化メチレン2.0ml溶液
を加え、トリエチルアミン243.7mg(2.408
mmol)と触媒量のDMAPを加えた後、アセチルク
ロライド189.0mg(2.408mmol)を0℃
でゆっくりと滴下し、同温度で10分間攪拌した。反応
液に飽和食塩水を加えることで反応を停止させた後、酢
酸エチルで抽出した。有機層を無水硫酸ナトリウムで乾
燥し、ろ過した。ろ液を減圧濃縮して得られた粗生成物
をシリカゲルカラムクロマトグラフィー(n−ヘキサ
ン:酢酸エチル=10:1)で単離精製を行い、目的物
(トランス体とシス体の混合物)(2d)355.0m
gを得た。収率93%In an argon atmosphere, 331.6 mg of the previously obtained (12b) was placed in a 30 ml two-necked eggplant type flask.
(1.204 mmol) in 2.0 ml of methylene chloride was added, and 243.7 mg (2.408) of triethylamine was added.
mmol) and a catalytic amount of DMAP, and 189.0 mg (2.408 mmol) of acetyl chloride was added at 0 ° C.
, And the mixture was stirred at the same temperature for 10 minutes. After the reaction was stopped by adding saturated saline to the reaction solution, the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the crude product obtained was isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 10: 1) to give the desired product (a mixture of trans and cis forms) (2d ) 355.0m
g was obtained. 93% yield
【0147】トランス体の1H−NMR(CDCl3,δ
ppm):0.00(s,9H),1.72(s,3
H)、3.61(d,J=14.52Hz,1H)、
3.78(d,J=14.52Hz,1H)、3.80
(s,3H)、5.86(s,1H)、7.08−7.
16(m,10H) 1 H-NMR (CDCl 3 , δ) of trans form
ppm): 0.00 (s, 9H), 1.72 (s, 3
H), 3.61 (d, J = 14.52 Hz, 1H),
3.78 (d, J = 14.52 Hz, 1H), 3.80
(S, 3H), 5.86 (s, 1H), 7.08-7.
16 (m, 10H)
【0148】シス体の1H−NMR(CDCl3,δpp
m):0.01(s,9H)、1.64(s,3H)、
3.53(s,2H)、3.81(s,3H)、6.5
4(s,1H)、7.08−7.16(m,10H) 1 H-NMR (CDCl 3 , δpp
m): 0.01 (s, 9H), 1.64 (s, 3H),
3.53 (s, 2H), 3.81 (s, 3H), 6.5
4 (s, 1H), 7.08-7.16 (m, 10H)
【0149】IR(neat,cm-1):2340,1
703,1567,1518,1224,760IR (neat, cm -1 ): 2340, 1
703, 1567, 1518, 1224, 760
【0150】(実施例11)1−(1−ベンジルオキシ
イミノ−2−フェニルエチル)−3−トリメチルシリル
プロピン−2−イル アセテート(2c)の加水分解 Example 11 1- (1-benzyloxy)
Imino-2-phenylethyl) -3-trimethylsilyl
Hydrolysis of propyn-2-yl acetate (2c)
【0151】[0151]
【化36】 Embedded image
【0152】20mlのナス型フラスコに、先に得た
(2c、トランス体:シス体=3.6:1の混合物)5
1.9mg(0.132mmol)を秤量し、THF
0.25mlとリン酸緩衝溶液)0.9mlを加え、1
0分間攪拌した後、リパーゼPS(316.8mg)を
加え、40℃で155.5時間攪拌した。反応液をセラ
イトろ過した後、ろ液を濃縮して組成生物を獲た。この
ものをシリカゲルカラムクロマトグラフィー(n−ヘキ
サン:酢酸エチル=10:1)により単離精製を行い、
(1a)を13.1mg得た。また、(2c)を36.
2g回収した。In a 20 ml eggplant-shaped flask, (2c, a mixture of trans-form: cis-form = 3.6: 1) 5
1.9 mg (0.132 mmol) was weighed, and THF was added.
0.25 ml and 0.9 ml of a phosphate buffer solution, and 1
After stirring for 0 minutes, lipase PS (316.8 mg) was added, and the mixture was stirred at 40 ° C. for 155.5 hours. After the reaction solution was filtered through celite, the filtrate was concentrated to obtain a constituent organism. This was isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 10: 1).
13.1 mg of (1a) was obtained. In addition, (2c) is set to 36.
2 g were recovered.
【0153】(収率) 1a:28%(トランス:シス=38.4:1の混合
物)、 2c:69%(トランス:シス=1.8:1の混合
物)。 (光学純度) 1aのトランス体:99%ee以上、5aのシス体:9
9%ee以上 2cのトランス体:37%ee、8aのシス体:11%
ee (旋光度) 1a:α[D](23℃)=+48.5(c=0.5
9,CHCl3) 2c:α[D](23℃)=+18.4(c=0.7
2.CHCl3)(Yield) 1a: 28% (mixture of trans: cis = 38.4: 1), 2c: 69% (mixture of trans: cis = 1.8: 1). (Optical purity) Trans form of 1a: 99% ee or more, cis form of 5a: 9
9% ee or more 2c trans form: 37% ee, 8a cis form: 11%
ee (optical rotation) 1a: α [D] (23 ° C.) = + 48.5 (c = 0.5
9, CHCl 3 ) 2c: α [D] (23 ° C.) = + 18.4 (c = 0.7
2. CHCl 3 )
【0154】(実施例12)1−(1−メトキシイミノ
−2−フェニルエチル)−3−トリメチルシリルプロピ
ン−2−イル アセテート(2d)の加水分解 Example 12 1- (1-Methoxyimino)
-2-phenylethyl) -3-trimethylsilylpropyl
Hydrolysis of N-2-yl acetate (2d)
【0155】[0155]
【化37】 Embedded image
【0156】20mlのナス型フラスコに、先に得た
(2d、トランス体:シス体=6.0:1の混合物)4
4.3mg(0.132mmol)を秤量し、THF
0.25mlとリン酸緩衝溶液0.9mlを加えて10
分間攪拌した後、リパーゼPS(39.6mg)を加え
て、40℃で84時間攪拌した。反応液をセライトろ過
し、炉易を濃縮して粗生成物を得た。このものをシリカ
ゲカラムクロマトグラフィー(n−ヘキサン:酢酸エチ
ル=10:1)により単離精製を行い、(1b)を1
2.4mg得た。また、(2d)を26.1mg回収し
た。In a 20 ml eggplant-shaped flask, (2d, mixture of trans-form: cis-form = 6.0: 1) 4
4.3 mg (0.132 mmol) was weighed, and THF was added.
Add 0.25 ml and 0.9 ml of phosphate buffer solution and add 10
After stirring for minutes, Lipase PS (39.6 mg) was added, and the mixture was stirred at 40 ° C for 84 hours. The reaction solution was filtered through celite, and the reactor was concentrated to obtain a crude product. This was isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 10: 1), and (1b) was converted to 1
2.4 mg were obtained. In addition, 26.1 mg of (2d) was recovered.
【0157】(収率) 1b:34%(トランス体:シス体=9.2:1) 2d:57%(トランス体:シス体=1.8:1) (光学純度) 1b:α[D](23℃)=+56.5(c=0.2
5,CHCl3) 2d:α[D](23℃)=+18.2(c=0.3
1,CHCl3)(Yield) 1b: 34% (trans form: cis form = 9.2: 1) 2d: 57% (trans form: cis form = 1.8: 1) (optical purity) 1b: α [D ] (23 ° C.) = + 56.5 (c = 0.2
5, CHCl 3 ) 2d: α [D] (23 ° C.) = + 18.2 (c = 0.3
1, CHCl 3 )
【0158】(実施例13)1−(1−ベンジルオキシ
イミノ−2−フェニルエチル)プロピン−2−イル プ
ロピオネート(2a)の加水分解 Example 13 1- (1-benzyloxy)
Imino-2-phenylethyl) propyn-2-yl
Hydrolysis of Lopionate (2a)
【0159】[0159]
【化38】 Embedded image
【0160】20mlのナス型フラスコに、先に得た
(2a、トランス体:シス体=6.0:1)51.9m
g(0.132mmol)を秤量し、THF0.25m
lとリン酸緩衝溶液0.9mlを加え、10分間攪拌し
たのち、リパーゼPS(39.6mg)を加え、40℃
で84時間攪拌した。反応液をセライトろ過し、ろ液を
濃縮して粗生成物を得た。このものをシリカゲルカラム
クロマトグラフィー(n−ヘキサン:酢酸エチル=5:
1)にて単離精製を行い、目的物(1a)を15.4m
gを得た。また、原料の(2a)を26.1mg回収し
た。In a 20 ml eggplant-shaped flask, 51.9 m of the previously obtained (2a, trans-form: cis-form = 6.0: 1) was obtained.
g (0.132 mmol) was weighed and THF 0.25m
and 0.9 ml of a phosphate buffer solution, and the mixture was stirred for 10 minutes, and then lipase PS (39.6 mg) was added.
For 84 hours. The reaction solution was filtered through celite, and the filtrate was concentrated to obtain a crude product. This was subjected to silica gel column chromatography (n-hexane: ethyl acetate = 5:
The target product (1a) was isolated and purified in 1) to obtain 15.4 m
g was obtained. In addition, 26.1 mg of the raw material (2a) was recovered.
【0161】(収率) 1a:41%(トランス体:シス体=49.4:1) 2a:59%(トランス体:シス体=2.1:1) (光学純度) 1a:α[D](23℃)=−108.1(c=0.2
5,CHCl3) 2a:α[D](23℃)=−75.9(c=0.4
9,CHCl3)(Yield) 1a: 41% (trans form: cis form = 49.4: 1) 2a: 59% (trans form: cis form = 2.1: 1) (optical purity) 1a: α [D ] (23 ° C.) = − 108.1 (c = 0.2
5, CHCl 3 ) 2a: α [D] (23 ° C.) = − 75.9 (c = 0.4
9, CHCl 3 )
【0162】(実施例14)1−(1−メトキシイミノ
−2−フェニルエチル)プロピン−2−イル プロピオ
ネート(2b)の加水分解 Example 14 1- (1-methoxyimino)
-2-phenylethyl) propyn-2-yl propio
Hydrolysis of Nate (2b)
【0163】[0163]
【化39】 Embedded image
【0164】20mlのナス型フラスコに、先に得た
(2b、トランス体:シス体=6.4:1)220.4
mg(0.850mmol)を秤量し、THF0.8m
lとリン酸緩衝溶液2.9mlを加え、10分間攪拌し
たのち、リパーゼPS(255.2mg)を加え、40
℃で45.5時間攪拌した。反応液をセライトろ過し、
ろ液を濃縮して粗生成物を得た。このものをシリカゲル
カラムクロマトグラフィー(n−ヘキサン:酢酸エチル
=4:1)にて単離精製を行い、目的物(1b)を6
5.0mgを得た。また、原料の(2b)を125.9
mg回収した。In a 20 ml eggplant-shaped flask, 220.4 (2b, trans-form: cis-form = 6.4: 1) was obtained.
mg (0.850 mmol) was weighed and the THF 0.8m
and 2.9 ml of a phosphate buffer solution, and after stirring for 10 minutes, lipase PS (255.2 mg) was added.
The mixture was stirred at 4 ° C. for 45.5 hours. The reaction solution was filtered through celite,
The filtrate was concentrated to obtain a crude product. This was isolated and purified by silica gel column chromatography (n-hexane: ethyl acetate = 4: 1) to give the desired product (1b) in 6 parts.
5.0 mg were obtained. Also, the starting material (2b) was converted to 125.9.
mg recovered.
【0165】(収率) 1b:38%(トランス体:シス体=22.2:1) 2b:57%(トランス体:シス体=1.8:1) (光学純度) 1b:α[D](23℃)=−111.1(c=1.
3,CHCl3) 2b:α[D](23℃)=−67.6(c=1.7
2,CHCl3)(Yield) 1b: 38% (trans form: cis form = 22.2: 1) 2b: 57% (trans form: cis form = 1.8: 1) (optical purity) 1b: α [D ] (23 ° C) = -111.1 (c = 1.
3, CHCl 3 ) 2b: α [D] (23 ° C.) = − 67.6 (c = 1.7)
2, CHCl 3 )
【0166】(実施例15)4−ベンジルオキシアミノ
−5−フェニルペント−1−イン−3−オール(13
a)の合成 Example 15 4-benzyloxyamino
-5-phenylpent-1-yn-3-ol (13
Synthesis of a)
【0167】[0167]
【化40】 Embedded image
【0168】アルゴン雰囲気下で、30mlの二口ナス
型フラスコに、VITRIDEのトルエン溶液206.2mg
(1.260mmol)を秤量し、THF1.5mlを
加え、先に得た(1c)44.0mg(0.158mm
ol、96%ee、トランス体:シス体=25.4:1
の混合物)のTHF1.5ml溶液を、−78℃で1.
5時間かけてゆっくりと滴下した。その後、−20℃ま
で2.5時間かけて自然昇温させた。反応液に2規定塩
酸を加えて反応を停止させ、酢酸エチルで抽出した。有
機層を無水硫酸ナトリウムで乾燥し、ろ過した。ろ液を
減圧濃縮して粗生成物を得た。このものをシリカゲルカ
ラムクロマトグラフィー(n−ヘキサン:酢酸エチル=
3:1)で単離精製して、目的物(異性体混合物)(1
3a)33.9mgを得た。収率77%In an argon atmosphere, 206.2 mg of a toluene solution of VITRIDE was placed in a 30 ml two-necked eggplant type flask.
(1.260 mmol) was weighed, and 1.5 ml of THF was added, and 44.0 mg (0.158 mm) of (1c) previously obtained.
ol, 96% ee, trans-form: cis-form = 25.4: 1
Of a mixture of the above) in 1.5 ml of THF at -78 ° C.
The solution was slowly dropped over 5 hours. Thereafter, the temperature was naturally raised to −20 ° C. over 2.5 hours. The reaction solution was quenched with 2N hydrochloric acid and extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure to obtain a crude product. This was subjected to silica gel column chromatography (n-hexane: ethyl acetate =
3: 1) to purify the desired product (isomer mixture) (1
3a) 33.9 mg were obtained. 77% yield
【0169】anti体の1H−NMR(CDCl3,δ
ppm):2.55(d,J=2.31Hz,1H)、
2.71−3.41(m,4H)、4.45−4.53
(br,1H)、4.67(s,2H)、5.84−
6.00(br,1H)、7.18−7.38(m,1
0H) 1 H-NMR (CDCl 3 , δ) of anti form
ppm): 2.55 (d, J = 2.31 Hz, 1H),
2.71-3.41 (m, 4H), 4.45-4.53
(Br, 1H), 4.67 (s, 2H), 5.84-
6.00 (br, 1H), 7.18-7.38 (m, 1
0H)
【0170】syn体の1H−NMR(CDCl3,δp
pm):2.53(d,J=1.98Hz,1H)、
2.71−3.41(m,4H)、4.45−4.53
(br,1H)、4.70(s,2H)、5.84−
6.00(br.1H)、7.18−7.38(m,1
0H) 1 H-NMR (CDCl 3 , δp
pm): 2.53 (d, J = 1.98 Hz, 1H),
2.71-3.41 (m, 4H), 4.45-4.53
(Br, 1H), 4.70 (s, 2H), 5.84-
6.00 (br.1H), 7.18-7.38 (m, 1
0H)
【0171】α[D](23℃)=+10.6(c=
0.68,CHCl3) IR(neat,cm-1):3400,3250,30
00,1505,1461,1230Α [D] (23 ° C.) = + 10.6 (c =
0.68, CHCl 3 ) IR (neat, cm −1 ): 3400, 3250, 30
00, 1505, 1461, 1230
【0172】[0172]
【発明の効果】以上説明したように、本発明によれば、
医薬品製造中間体等として有用な光学活性β−イミノア
ルコール類およびβ−アミノアルコール類を、高い光学
純度で簡便に製造することができる。As described above, according to the present invention,
Optically active β-imino alcohols and β-amino alcohols useful as pharmaceutical production intermediates and the like can be easily produced with high optical purity.
Claims (6)
数7〜20のアラルキル基を表し、R2は、炭素数1〜
6のアルキル基、炭素数7〜20のアラルキル基または
炭素数1〜6のハロアルキル基を表し、R3は、炭素数
1〜6のアルキル基または炭素数7〜20のアラルキル
基を表し、R4は、水素原子、炭素数1〜6のアルキル
基またはトリメチルシリル基を表す。)で表される化合
物をリパーゼを用いて加水分解する工程を有する、式
(1) 【化2】 (式中、R1、R2およびR4は、前記と同じ意味を表
す。)で表される光学活性β−イミノアルコールの製造
方法。(1) Formula (2) (In the formula, R 1 represents an alkyl group or an aralkyl group having 7 to 20 carbon atoms having 1 to 6 carbon atoms, R 2 is 1 to the number of carbon atoms
6 represents an alkyl group having 6 to 6 carbon atoms, an aralkyl group having 7 to 20 carbon atoms or a haloalkyl group having 1 to 6 carbon atoms; R 3 represents an alkyl group having 1 to 6 carbon atoms or an aralkyl group having 7 to 20 carbon atoms; 4 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or a trimethylsilyl group. ) Having a step of hydrolyzing the compound represented by formula (1) using a lipase. (Wherein, R 1 , R 2 and R 4 have the same meanings as described above).
表す。)表される化合物を、リパーゼを用いて加水分解
することによって、式(1) 【化4】 (式中、R1、R2およびR4は前記と同じ意味を表
す。)で表される光学活性β−イミノアルコールを得る
工程と、前記式(1)で表されるβ−イミノアルコール
を還元する工程とを有する、式(3) 【化5】 (式中、R1、R2およびR4は、前記と同じ意味を表
す。)で表される光学活性β−アミノアルコールの製造
方法。2. A compound of the formula (2) (Wherein, R 1 , R 2 , R 3 and R 4 have the same meanings as described above.) The compound represented by the formula (1) is hydrolyzed using a lipase. (Wherein R 1 , R 2 and R 4 have the same meanings as described above), and a step of obtaining an optically active β-imino alcohol represented by the formula (1): (3) having a step of reducing (Wherein, R 1 , R 2 and R 4 have the same meanings as described above).
表す。)で表される化合物。(3) Formula (2) (Wherein, R 1 , R 2 , R 3 and R 4 represent the same meaning as described above).
す。)で表される光学活性β−イミノアルコール化合
物。4. A compound of the formula (1) (Wherein, R 1 , R 2 and R 4 have the same meanings as described above).
す。)で表される光学活性β−アミノアルコール化合
物。5. A compound of the formula (3) (In the formula, R 1 , R 2 and R 4 have the same meanings as described above.)
される化合物。6. A compound of the formula (9) (Wherein, R 1 and R 2 have the same meanings as described above).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000092551A JP2001275691A (en) | 2000-03-29 | 2000-03-29 | OPTICALLY ACTIVE beta-IMINO ALCOHOL AND beta-AMINO ALCOHOL, PRODUCTION INTERMEDIATE, AND METHOD FOR PRODUCING THEM |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000092551A JP2001275691A (en) | 2000-03-29 | 2000-03-29 | OPTICALLY ACTIVE beta-IMINO ALCOHOL AND beta-AMINO ALCOHOL, PRODUCTION INTERMEDIATE, AND METHOD FOR PRODUCING THEM |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001275691A true JP2001275691A (en) | 2001-10-09 |
Family
ID=18607868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000092551A Pending JP2001275691A (en) | 2000-03-29 | 2000-03-29 | OPTICALLY ACTIVE beta-IMINO ALCOHOL AND beta-AMINO ALCOHOL, PRODUCTION INTERMEDIATE, AND METHOD FOR PRODUCING THEM |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001275691A (en) |
-
2000
- 2000-03-29 JP JP2000092551A patent/JP2001275691A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3789938B2 (en) | Racemic resolution of primary and secondary heteroatom-substituted amines by enzyme-catalyzed acylation | |
| CA2857078A1 (en) | Process for producing chiral statin side chain intermediates employing candida/antarctica lipase b | |
| WO2012059830A1 (en) | Manufacturing process for (s)-pregabalin | |
| US7358382B2 (en) | Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production | |
| US5447865A (en) | Method of resolution of hydroxy substituted cyclopentanone enantiomers using lipase and lithium salt complexation | |
| JP2001275691A (en) | OPTICALLY ACTIVE beta-IMINO ALCOHOL AND beta-AMINO ALCOHOL, PRODUCTION INTERMEDIATE, AND METHOD FOR PRODUCING THEM | |
| US7803950B2 (en) | Method for the production of diarylcycloalkyl derivatives | |
| JPH1057094A (en) | Enzymatic optical resolution of alcohol using ketene acetal type acylating agent | |
| US8927237B2 (en) | Method for producing acyloxypyranone compound, method for producing alkyne compound, and method for producing dihydrofuran compound | |
| JP2001278871A (en) | Oxazolidine compound and method for producing the same | |
| JP2003512034A (en) | Method for producing chiral ester | |
| EP1086942B1 (en) | Optically active alcohols and processes for the preparation thereof | |
| JPH06256278A (en) | Optically active alpha-carbamoylalkanoic acid derivative and its production | |
| JPH09143173A (en) | Optically active 5,5-diphenyl-2-oxazolidinone derivative | |
| JP2709807B2 (en) | Process for producing 3-chloro-4-silyloxy-2-cyclopenten-1-ones | |
| JP3726332B2 (en) | Process for producing optically active dicyclopentadiene derivatives | |
| JP2609922B2 (en) | 2'-Ketopantothenic acid ester | |
| CN100352821C (en) | Rosuvastain calcium intermediate preparation method | |
| US7368568B2 (en) | Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use | |
| JP2000007609A (en) | Production of carboxylic acid derivative | |
| JP2008507487A (en) | Process for the preparation of (2R, 3R) -2-hydroxy-3-amino-3-aryl-propionamide and (2R, 3R) -2-hydroxy-3-amino-3-aryl-propionic acid alkyl esters | |
| JP4599691B2 (en) | Optically active compound and method for producing the same | |
| JP3918956B2 (en) | Method for producing 1-azidoindan-2-ol | |
| JPH0847398A (en) | Process for producing optically active propargyl alcohol compound | |
| JP2001025395A (en) | Method for producing optically active 4-hydroxy-2,6,6-trimethyl-2-cyclohexen-1-one |